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ABSTRACT
Background: As maternal mortality is very low in high resource settings, a complimentary 
indicator to assess obstetric care is needed. Severe maternal morbidity is suggested as a useful 
indicator as it occurs more frequently. Severe obstetric haemorrhage is the main cause of 
severe maternal morbidity and mortality worldwide.  Norway is characterised by a low 
maternal mortality and a well established registry of all births. However, large population-
based studies on the proportion, causes and risk factors of severe obstetric haemorrhage are 
lacking. Uterine rupture, one of the causes of severe haemorrhage, is expected to rise due to 
the increased rates of caesarean section (CS). Yet, we do not have documentation of the 
proportion and impact of uterine rupture after previous CS in Norway. Information about 
severe obstetric haemorrhage and uterine rupture is warranted for both preventive and 
curative health services.  
Aims: to determine the proportion, risk factors, causes and maternal outcome of severe 
obstetric haemorrhage with emphasis on the role of increasing obstetric procedures as 
induction and CS. Another aim was to determine the proportion, risk factors and maternal and 
perinatal outcome of uterine rupture after previous CS. 
 
Materials and Methods: We used data from the Medical Birth Registry of Norway on all 
women giving birth after 16 weeks gestations in 1999-2004 for the study of severe obstetric 
haemorrhage (307 415 mothers). Data on mothers with gestations 28 weeks, giving birth 
after previous CS in 1999-2005, were used for the study of uterine rupture (18 794 mothers). 
The main outcome measures included severe obstetric haemorrhage (blood loss >1500 
ml/need for blood transfusion) and uterine rupture. Secondary maternal outcomes were 
maternal death, peripartum hysterectomy, admission to intensive care unit, acute renal failure, 
and postpartum sepsis. Serious perinatal outcomes included perinatal death, post hypoxic 
encephalopathy and severe asphyxia. The explanatory variables consisted of demographic and 
medical variables, pregnancy and labour complications, and delivery mode variables. Cross 
tabulations and multiple logistic regressions were used and associations were measured as 
relative risks (estimated odds ratios). 
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Results:
 Severe obstetric haemorrhage occurred in 1.1% of all mothers. Uterine atony was the 
main cause. One third of cases has unidentified causes, especially at caesarean section. 
Mothers with severe obstetric haemorrhage had significantly higher risk for serious 
maternal outcome. 
 The mode of delivery was the most important risk factor for severe obstetric haemorrhage, 
especially emergency CS, followed by elective CS. Other important risk factors included 
multiple pregnancy, von Willebrand’s disease, HELLP syndrome, anaemia during 
pregnancy and macrosomia.  
 Prelabour CS and induction significantly increased the risk for severe postpartum 
haemorrhage (PPH) compared with spontaneous labour onset.  
 Vaginal deliveries halved the risk of severe PPH compared with prelabour CS even in 
mothers with previous CS. 
 Emergency CS after labour onset had the highest risk for severe PPH in all mothers, but 
especially after induction in women with previous CS.  
 Operative vaginal delivery after induction significantly increased severe PPH risk in 
primiparas. 
 Uterine rupture occurred in 5/1000 of mothers with previous CS. The highest risk was for 
induced labour, especially with prostaglandins, and for emergency prelabour CS, while 
the lowest risk was for repeated elective CS.  
 Uterine rupture after trial of labour was significantly associated with serious maternal and 
perinatal outcome. 
 Older age and ethnicity were significant risk factors for both severe obstetric haemorrhage 
and uterine rupture. 
Conclusion:
For every 100 women giving birth in Norway, one woman develops severe obstetric 
haemorrhage, with a higher risk of adverse outcome. Severe haemorrhage was in a major part 
related to obstetric procedures and labour management indicating that induction and prelabour 
CS should be practiced with caution. However, prelabour CS might be a better option for 
mothers with previous CS if the probability of emergency CS is high. Uterine rupture after 
trial of labour carried a greater risk of adverse maternal and perinatal outcome compared with 
elective repeated CS, although the absolute risks were low. 
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DEFINITIONS AND ABBREVIATIONS 
 
 
Definitions:
Macrosomia (applied only for this study): Birth weight  4.5 kg. 
 
Maternal death: The death of a woman while pregnant or within 42 days of termination of 
pregnancy, from any cause related to or aggravated by pregnancy or its management, but not 
from accidental or incidental causes. 
 
 
Maternal Mortality Ratio: Maternal deaths per 100 000 live births. 
 
Mechanical induction methods: Amniotomy alone or other non-medical induction methods. 
  
 
Moderate postpartum haemorrhage: Visually estimated blood loss 500-1500 ml, within 24 
hours postpartum. 
 
 
Perinatal death (applied only for this study): Sum of Intrapartum fetal deaths  28 weeks 
gestation, and neonatal deaths 7 days after birth, not related to congenital causes. 
Antepartum stillbirths were excluded in the present study since they were not delivery-related. 
 
 
Perinatal mortality rate: Sum of stillbirths at 22 weeks and deaths of live born infants within 
the first seven days after birth per 1000 total births. 
 
 
Post hypoxic encephalopathy: Defined clinically as cerebral irritation, cerebral depression, or 
seizures in the presence of severe asphyxia. 
 
 
Severe Obstetric Haemorrhage: Visually estimated blood loss of >1500 ml intrapartum and 
within 24 hours post-partum, or the need for blood transfusion postpartum regardless of the 
amount of blood loss. 
 
 
Severe postpartum haemorrhage: Defined as severe obstetric haemorrhage, excluding 
haemorrhages due to placenta previa and abruption.  
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Abbreviations: 
 
CI: Confidence interval. 
CS: Caesarean section.    
DIC: Disseminated intravascular coagulation. 
EUPHRATES: The EUropean Project on obstetric Haemorrhage Reduction: Attitudes, Trial 
and Early warning System.  
FIGO: International Federation of Gynaecology and Obstetrics. 
HELLP syndrome: Haemolysis elevated liver enzymes & low platelets. 
ICD-10: The International statistical classification of diseases and related health problems, 
10th revision.  
ICU: Intensive care unit. 
NICU: Neonatal intensive care unit. 
IMC: International Confederation of Midwives. 
MBRN: The Medical Birth Registry of Norway. 
MMR: Maternal Mortality Ratio. 
MOMS:  MOthers Mortality and Severe Morbidity.  A European initiative. 
NOMESCO: The Nordic Medico-Statistic Committee. 
NCSP: NOMESCO Classification of Surgical Procedures.  
OR: Odds Ratio. 
PHE: Post hypoxic encephalopathy. 
PPH: Postpartum haemorrhage. 
TOL: Trial of labour. 
UKOSS: The UK Obstetric team Surveillance System. 
WHO: World Health Organisation. 
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INTRODUCTION
For every minute of every day worldwide, a woman dies due to pregnancy and childbirth.1 
The majority of deaths are from severe obstetric haemorrhage. Most of these deaths could 
have been prevented1–3 if only sufficient resources had been available during childbirth. Most 
deaths occur in low resource settings. In high resource settings, with few fatalities from 
haemorrhage, severe obstetric haemorrhage stands as the main severe maternal morbidity.4–9  
The main focus of the current thesis was to study the proportion, causes, risk factors, and 
outcome of severe obstetric haemorrhage in a high resource setting with adequate registration 
of births. The emphasis was placed on factors increasingly applied in obstetric practice, such 
as delivery by caesarean section (CS), and induction of labour. As CS rate is increasing 
worldwide, special emphasis was placed on uterine rupture after previous CS.10 Uterine 
rupture is an important cause of severe obstetric haemorrhage and is associated with both 
serious perinatal and maternal outcome.11, 12 Increasing knowledge on severe obstetric 
haemorrhage may reduce its occurrence and its impact on maternal health. It may also 
contribute toward lower maternal mortalities in low resource settings.  
Why focus on severe obstetric haemorrhage? 
From ancient times, obstetric haemorrhage has remained a major killer of mothers. It stands 
behind the shadows of the Taj Mahal in India. The Taj Mahal was built by the grieving 
Emperor Shah Jehan in the memory of his wife Empress Mumtaz Mahal, who died in 1630 
from postpartum haemorrhage after delivering her 14th child.13 Severe obstetric haemorrhage 
is also behind the Triple Tragedy in England in 1817.14 At the age of 21, Princess Charlotte, 
George IV only child, went into labour with her first baby. She delivered a stillborn boy after 
50 hours of labour. Six hours later, she died from postpartum haemorrhage. The obstetrician, 
who was widely criticised, shot himself few months later. King George was left without an 
heir, and the throne passed first to his brother and then to his niece, who became Queen 
Victoria.   
 
We chose to concentrate on the epidemiology of severe obstetric haemorrhage for the 
following reasons:  
1. Severe obstetric haemorrhage is the main cause of maternal deaths.1–3, 15  
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2. Severe obstetric haemorrhage is the most common severe maternal morbidity in high- and 
low- resource settings. 4–9 It may result in serious physical and psychological short-term 
and long-term disability.2 It has grave consequences that affect not only the mother, but 
also the newborn, other family members and society at large.  
3. Severe obstetric haemorrhage is the most preventable severe maternal complication, and 
suboptimal obstetric care was identified in more than half the deaths due to haemorrhage, 
even in high resource settings16, 17 
 
Obstetric haemorrhage is the most feared obstetric emergency that can occur to any woman at 
childbirth.  If unattended, haemorrhage can kill even a healthy woman within two hours.19, 20 
The global estimate of deaths due to haemorrhage is 150 000 per year.3 Haemorrhage 
accounts for nearly one quarter of all maternal deaths, and for almost half of all postpartum 
deaths in low-income countries.3, 20, 21 If we manage to reduce severe obstetric haemorrhage, a 
major reduction of maternal mortality and morbidity would be achieved worldwide.  
Recent studies in high resource settings18 including Canada,22 USA,23 
Australia,24 and UK25 indicate an unexpected and unexplained increase in obstetric 
haemorrhage over the last ten years. Although maternal deaths are extremely rare in high 
resource settings, the morbidity associated with severe haemorrhage is still a major problem.6, 
8, 25–27 Many more women survive, but suffer serious illness as a result, not only from the 
effects of acute hypo-perfusion and anaemia, but also from the interventions which severe 
haemorrhage may necessitate.28, 29 It can furthermore affect the health of the newborn through 
weakening of mother’s health and subsequent reduced bonding.20, 30 All factors considered, 
severe haemorrhage also poses substantial costs to the health care system and to society in 
general. It is therefore suggested as a complimentary indicator for the assessment of  the 
quality of obstetric care.32–33 This necessitates the performance of large population studies in 
order to determine the proportion and risk factors of severe obstetric haemorrhage.  
 
Norway is a high resource country, characterised by a low maternal mortality ratio (MMR) of 
4.1-5.5/ 100 00034,35, and a well established registry of all births. Few maternal deaths from 
severe obstetric haemorrhage were detected according to a study review of case records in 
1976-1995.35 However, deaths from haemorrhage were all found to be avoidable. In addition, 
large population-based studies on the proportion and risk factors of severe obstetric 
haemorrhage are lacking. Such information is warranted for both preventive and curative 
health services. The data in the Medical Birth Registry of Norway (MBRN), established since 
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1967, is a relevant source of data for such a study.36, 37  As of 1999, severe obstetric 
haemorrhage is recorded in specific ticked boxes in the MBRN registration forms. 
 
Severe maternal morbidity: an important indicator of obstetric care 
Each year, more than half a million women die from causes related to pregnancy and 
childbirth: 99% of the deaths occur in poor countries, with the majority in sub-Saharan Africa 
and South Asia.1, 15 The risk of a woman dying as a result of pregnancy or childbirth during 
her lifetime is about one in six in the poorest parts of the world, compared with one in 30 000 
in Northern Europe.1, 15  
One hundred and fifty years ago, the rate and causes of maternal deaths in Scandinavia were 
similar to those observed in the least developed world today.38, 39  Maternal deaths were 
mainly due to obstetric haemorrhage, infections, eclampsia, prolonged or obstructed labour 
and complications of abortion. Significant reductions in MMR were accomplished first in 
North-western Europe in the mid- to late 19th century.40 This was mainly due to the increased 
coverage of deliveries by skilled professional midwives, established first in Scandinavia 
during 1860-1900.41–43 In the 1940s, obstetric haemorrhage was the most common cause of 
maternal mortality in UK44 and the USA.45The most dramatic reduction in MMR in the 
industrialized world occurred after the Second World War. This was due to the improved 
health and nutrition of women and universal access to modern obstetric medicine,40 
comprising the introduction of antiseptics, improving operative deliveries, anaesthesia, 
antibiotics, blood transfusion and the use of uterotonics against postpartum haemorrhage. The 
MMR remained generally static at 8 per 100,000 live births between 1990 and 2005.15  
  
As maternal death is becoming rare in the industrialized world, the safety of childbirth is 
generally taken for granted.  Services are encouraged to provide choice, including home or 
hospital delivery, epidurals, or water births. A growing number of women opt for planned 
caesarean section without real indication. As a result, the CS rate is increasing in many 
countries with consequent increased short- and long- term complications.28, 29, 46–-48 However, 
the sharpest increase in CS rates is found in fact in urban areas of South-America, Asia and 
Africa.49 
By looking only at maternal deaths, we may overlook other major problems in obstetric 
care.50 Maternal deaths are only the tip of the iceberg; severe maternal morbidity is a huge 
burden on women and their families.  Mantel, et al31 defined woman with severe maternal 
morbidity as ‘a very ill pregnant or recently delivered woman who would have died had it not 
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been but that luck and good care was on her side’. In industrialised countries, the rates range 
from 0.05 to 1.7%, depending on the definition used.51, 52   
Analysis of severe maternal morbidities is a new area of research as they can be used as a 
complementary indicator of obstetric care. The case fatality ratio (Death/Severe morbidity) is 
an objective indicator of obstetric care, with very low ratio in high resource countries, and 
very high ratio in countries with low resources.9 The demographic and other characteristics as 
well as management aspects can be compared between mothers who survived a severe 
maternal morbidity and mothers who died from the same severe morbidity. Regular audits of 
severe morbidity cases may improve the quality of obstetric care.
History of obstetric medicine in Norway  
Women in the 19th century could have contractions for days. Nothing was usually done before 
the infant was dead or the mother was seriously ill.38,42 The first dramatic reduction of 
maternal mortality, observed in Norway from the second half of the 19th century (6.7/1000 in 
1860 to 3.3/1000 in 1900), was due to the increased numbers of professional midwives and 
decreased puerperal fever.41-43 The increased use of Simpson’s forceps contributed to a 
dramatic reduction of prolonged labour and postpartum haemorrhage.107 It was used initially 
to save mothers life, but fetal indications became more frequent towards the end of  the 19th 
century.108  The first CS in Norway resulting in a living child, was performed in 1849, but no 
mother survived the operation before 1890.109 In the 19th century, CS was performed rarely 
due to high mortalities from CS related to infection and haemorrhage. The mortality from CS 
was reduced dramatically through the 20th century due to developments in surgical technique, 
introduction of antibiotics, blood transfusion, improvement in postoperative care, and epidural 
anaesthesia. CS became more frequent as a result, especially after the 2nd World War.109 This 
contributed to less obstetric haemorrhage from placenta previa, abruption and uterine atony. 
In 1915, Christian Kjelland (1871-1941), a Norwegian obstetrician from Rikshospitalet, 
designed rotational forceps.110 Kjelland forceps were used internationally for extraction of the 
incompletely rotated head from the upper pelvis, and for deep transverse arrest of the head, 
avoiding emergency CS in late stage of labour. 
The second dramatic reduction in MMR in Norway was after the Second World War.34 MMR 
in Norway was 2.34/1000 in 1936-1940, but dropped to 0.74/1000 in 1951-1956 (Figure 1),111 
due to universal access to modern obstetric medicine and immediate emergency care.  From 
1976 to 2000, the MMR was 4.1-5.5/100 000 live births with preeclampsia as the main cause 
of maternal deaths34, 35 
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Figure 1. Maternal Mortality Ratio per 100 000 in Norway 1931-2005
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Perinatal mortality dropped from 35/1000 in 1901112 to 4.3/ 1000 in 2008.85 The vacuum 
extractor, invented by Tage Malmstrøm of Sweden, was used for the first time in Norway in 
1960.113 The vacuum does not need a very high level of skill, unlike Kjelland’s forceps, but 
nonetheless has a higher failure rate. Vacuum deliveries increased gradually in contrast to 
forceps, which started declining from the eighties.113 The maximum rate of forceps usage was 
4.5% in 1986, declining thereafter until it reached 1.8% in 2008. In contrast, use of vacuum 
delivery increased from 1.2% in 1967 to 7.9% in 2008. The rate of CS increased from 1.8% in 
1967 to 17.1% in 2008.85 Ironically, this dramatic growth in the rate of CS might increase 
severe haemorrhage due to both surgery complications and reduced skills in performing 
instrumental vaginal delivery. The CS rate of 17.1% in Norway today is however, still lower 
than in many other countries.
 
Challenges in epidemiological studies on severe obstetric haemorrhage 
1. Problems in defining severe obstetric haemorrhage 
Obstetric haemorrhage refers to excessive blood loss from the genital tract, occurring 
antepartum, intrapartum, or in the postpartum period. The most common type of obstetric 
haemorrhage is postpartum haemorrhage (PPH), mainly primary PPH, occurring within 24 
hours postpartum. Primary PPH has been the focus of this thesis. Secondary PPH is less 
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common, occurring between 24 hours and 6 weeks postpartum, most likely due to infection 
secondary to retained placental products.53   
Any review on obstetric haemorrhage is complicated by the lack of agreement on what 
constitutes excessive blood loss. Primary PPH is defined according to WHO (World Health 
Organisation) as blood loss > 500 ml in the first 24 hours postpartum.54 This is debatable, 
because nearly half of all women who are delivered vaginally shed that amount of blood, or 
more, when measured objectively.  Blood loss of more than 500 ml is not necessarily unusual 
for vaginal delivery.55 Furthermore, women with low body mass index have usually low 
blood volume, and women who are anaemic or having severe preeclampsia might have fewer 
physiological reserves to withstand blood loss. Hence, these patients might not be able to 
tolerate even 500 ml of blood loss, and will therefore decompensate sooner.56, 57  
Other proposed definitions of haemorrhage include a 10% decrease in haemoglobin or 
hematocrit level, or the need for blood transfusion.58 Given the delay in obtaining laboratory 
values, this information would not reflect the patient’s current hemodynamic status. The 
change in hematocrit depends on the timing of the test and the amount of fluid previously 
administered.59 It could also be affected by extraneous factors such as prepartum 
hemoconcentration, which may exist in conditions such as preeclampsia. 57  Any definition 
based on the need for blood transfusion is problematic and may reflect differences in provider 
practice patterns rather than patient clinical status.60 
In an attempt to combine clinical presentation with objective data, obstetric haemorrhage may 
best be defined as excessive bleeding that makes the patient symptomatic (light-headedness, 
syncope) and/or results in signs of hypovolemia (hypotension, tachycardia, or oliguria)61 
(Table 1).  
 
 
     Table 1. Symptoms and signs related to blood loss with obstetric haemorrhage 
Blood loss 
 
 
 
Systolic blood pressure 
(mmHg) 
 
Signs and symptoms 
% ml   
 
10–15 
 
 
500–1000 
 
 
normal 
 
 
palpitations, dizziness, tachycardia 
 
15–25 
 
1000–1500 
 
slightly low 
 
weakness, sweating, tachycardia 
 
25–35 
 
1500–2000 
 
70–80 
 
restlessness, pallor, oliguria 
 
35–45 
 
2000–3000 50–70 collapse, air hunger, anuria 
     Adapted from Bonnar J. Baillieres Best Pract Res Clin Obstet Gynaecol 2000; 14:161 
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We used a combination of blood loss or need for blood transfusion to identify severe 
haemorrhage. Blood transfusion is rarely given to mothers with haemoglobin 7gm/dl in 
Norway.62 It is given only to mothers with a clinical picture of acute anaemia.  
Classifying haemorrhage according to severity is another problem. There is a lack of 
agreement on a reproducible clinical definition of severe obstetric haemorrhage that can be 
identified easily and accurately. Some researchers have used a strict definition including only 
women admitted to an intensive care unit (ICU).63–69 This however, underestimates the real 
proportion, since only one third of cases of severe morbidity are transferred to ICU.7 Others 
included only those who required hysterectomy7 resulting in considerable variations due to 
different management policies. Even those who used clinical definitions based on the amount 
of blood loss have used different limits, varying from >1000 ml70 to  2500 ml.7, 25  
 It has been suggested that the definition should take into account any blood loss that causes a 
major physiological change which threatens mother’s life.61 This is especially important in 
cases of concealed intra-abdominal bleeding. The combination of blood loss 1500 ml or the 
transfusion of > 4 units of blood postpartum or drop of haemoglobin by 4 gm was used as a 
definition of severe obstetric haemorrhage in certain studies.6, 8  
In the present thesis severe obstetric haemorrhage was defined as a visually estimated blood 
loss of >1500 ml intrapartum and within 24 hours postpartum, or the need for blood 
transfusion postpartum, regardless of the amount of blood loss. We used a cut-off for severe 
haemorrhage of >1500 ml representing 25% of the blood volume, since blood loss of such an 
amount would lead to hemodynamic decompensation.71
2. Estimation of blood loss 
Visual estimation is the most universal method used to assess blood loss at delivery. It is 
relatively straightforward and requires no expenditure.72 Visual estimation is the standard 
method in Norway. The major advantage of this method is that it is a real time assessment. It 
enables the birth attendant to correlate findings, on an individualized basis, with the clinical 
presentation. However, visual estimation of blood loss is known to underestimate the actual 
loss by 30–50%.55, 73 
Standardized visual estimation is an attempt to rectify this error, based on training of 
providers and standardization of the size and quality of the pads used during delivery. 
Instruction in this method has significantly reduced the error in blood loss estimation for 
inexperienced as well as experienced clinicians.74 
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Direct collection of blood into bedpan or plastic bags immediately after the delivery of the 
newborn and clamping the cord, is another method used in some studies.72 This method has 
errors arising from failure to collect all the blood in stained linen or within the placenta, 
mixing of blood with amniotic fluid, and technical inaccuracies. Acid hematin method and 
measurement of tagged erythrocytes were referred to in earlier studies.55, 76 However, they 
were not used in practice as they require larger resources and consist of several impractical 
procedures.  
BRASSS-V DRAPE is a special drape which has a calibrated and funnelled collecting pouch, 
incorporated within a plastic sheet that is placed under the woman’s buttocks, immediately 
after delivery of the baby. This simple, practical tool has the potential for a more accurate 
detection of blood loss and would lead to earlier interventions contributing to reduction of 
both mortality and severe morbidity.77 
A study using collector bags for measuring blood loss at delivery was performed by The 
EUPHRATES group (EUropean Project on obstetric Haemorrhage Reduction: Attitudes, 
Trial and Early warning System. The group performed a multi-centre European study to 
determine whether severe postpartum haemorrhage would occur less if blood loss was 
measured objectively by collector bags.78 Severe PPH was defined as a composite of one or 
more of: blood transfusion, intravenous plasma expansion, arterial embolisation, surgical 
procedure, admission to ICU, treatment with recombinant factor VII, and death. In 2006-
2007, maternity units, including two units from Norway were randomly assigned to 
systematic use of collector bags or to continue to visually assess postpartum blood loss after 
vaginal delivery.78 The results showed that the use of collector bags did not reduce the rate of 
severe PPH compared with visual estimation. This indicates that the management of 
postpartum haemorrhage was not improved by objective measurement of blood loss without 
specific guidelines on threshold and action.
3. The use of different methods in conducting third stage of labour 
Active management of the third stage of labour as recommended by FIGO (International 
Federation of Gynaecology and Obstetrics) and IMC (International Confederation of 
Midwives) involves the use of prophylactic uterotonics such as syntocinon or syntometrine 
with the delivery of the fetal anterior shoulder clamping of the umbilical cord once pulsations 
stopped, controlled cord traction using the Brandt-Andrews technique once uterine 
contraction is achieved.79 In contrast, expectant management involves waiting for 
spontaneous separation of the placenta from the uterine wall and avoidance of synthetic 
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uterotonics. A meta-analysis indicated that active management of the third stage resulted in 
reduction in maternal blood loss, and a reduction in the risks of PPH.80 Clearly, the reported 
incidence of PPH in any population is influenced by the conduct of the third stage. As active 
management is not homogeneously performed, even across Europe,81 this must be taken into 
consideration when making comparisons of severe PPH incidence in different studies.  
 
4. The proportion of severe obstetric haemorrhage 
4.a Denominator data 
Studies that attempt to quantify the proportion and impact of severe obstetric haemorrhage 
need a denominator value over a specified time period. Common denominators are 
maternities or live births, and these can include early gestations from 16 weeks, as in our 
present study. Most of the previous studies included pregnancies from 24 weeks or even later 
gestations. High resource settings in contrast to low resource settings have the advantage of 
accurate denominator data, including both live births, still births and late miscarriages. When 
the denominators represent the total pregnant population, the estimate would be more reliable. 
4.b Impact of population characteristics and study design
The proportion of severe obstetric haemorrhage is influenced by the study design and 
population characteristics as well as obstetric management.  A systematic review of 
international studies was performed covering the period 1997-2006 of 120 data sets reporting 
PPH (blood loss >500 ml), and 70 data sets reporting severe PPH (blood loss > 1000 ml).82 
The percentage of PPH and severe PPH was approximately 6% and 1.86% of all deliveries, 
respectively. The proportion of severe PPH was 3.04% when the outcome was measured 
objectively and 1.68% when it was assessed subjectively. The incidence was 1.67% and 
2.95%, in population-based and institution-based studies respectively. The percentage was 
3.75% when the sample size was  1000 women and 1.78% for those studies with > 1000 
women. It was 3.84% for expectant management and 2.99% for active management of third 
stage of labour. Severe PPH for vaginal deliveries was 2.94%, and 6.38% for caesarean 
section. The incidence of severe PPH across global regions was 2.21% in Africa, 1.78% in 
Asia, 1.75% in Europe, 5.33% in Latin America and 4.33% in Oceania. However, there was 
small number of data sets in the latter two regions.      
 
The incidence of severe haemorrhage varies considerably, even between countries with high 
resources. This can be partly due to the use of different definitions as well as differences in 
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registration methods or management aspects.  However, other factors as different population 
characteristics may contribute to such variations. The MOMS (MOthers Mortality and Severe 
Morbidity) Survey8 was conducted during the 1990s by an international team which spanned 
11 European countries. Using unified clinical definitions of severe obstetric haemorrhage 
(blood loss 1500 ml or blood/plasma expanders transfusion, or death), the survey found a 
total incidence of severe haemorrhage of 4.6/1000 deliveries. However the incidences varied 
widely from 0.7/1000 in Austria to 8.8/1000 in Finland.8 The survey established that MMR 
were not higher in the countries with the highest severe haemorrhage rates, i.e. Belgium, 
Finland and the UK. This suggests either that ascertainment of cases in these three countries is 
more complete, or that haemorrhage is not a major cause of death, or that the low mortality 
rate is due to proper management of severe obstetric haemorrhage.  The geographical areas 
chosen in different countries had very different demographics (age and ethnic origin), and this 
also may have affected the rates of severe haemorrhage.  In both the UK and Belgium, the 
study covered areas with larger percentages of immigrants. Genetic profiles vary between 
different populations, as certain populations have increased hereditary coagulation disorders, 
or increased severe preeclampsia, predisposing to increased severe obstetric haemorrhage. 
The Finnish population for example, has a higher occurrence of placental abruption compared 
with other populations.83
5.  Causes and risk factors of severe obstetric haemorrhage  
The most common causes of obstetric haemorrhage are those related to primary PPH, (The 
Four Ts: Tone, Trauma, Tissue, and Thrombin) (Table 2). Uterine atony accounts for more 
than 70% of cases, retained placental products accounts for approximately 10%, genital-tract 
trauma (uterine rupture and inversion, cervical and perineal injuries) accounts for 20%, and 
pre-existent or acquired coagulation disorders and platelets dysfunction account for 1% of 
cases.84 Ante/intra-partum haemorrhage was reported to occur in about 3%-4% of pregnant 
population.85, of which 30% was due to placental abruption, and 20% was due to placenta 
previa. Both are associated with increased risk for postpartum haemorrhage.86 Placenta previa 
may be associated with abnormal adherent placenta (placenta accrete/increta or percreta), 
especially in the presence of uterine scar. 
Uterine rupture is one of the causes of severe obstetric haemorrhage. We focused on uterine 
rupture as it is associated with severe maternal haemorrhage and adverse fetal outcome. 
Uterine rupture is expected to increase due to increasing rates of CSs.11, 12, 88 
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     Table 2. Etiology and risk factors for the 4Ts processes involved in postpartum haemorrhage87 
Process Etiology Risk factor 
 
Tone  Uterus over-distension Multiple pregnancy; Macrosomia, 
Polyhydramnios; Fetal abnormalities 
 Uterine muscle fatigue Prolonged/precipitate labour. 
High parity; Previous pregnancy with PPH 
 Uterine 
infection/chorioamnionitis 
Prolonged SROM; Fever 
 Uterine distortion/abnormality Fibroid uterus; Placenta previa 
 Uterine relaxing drugs Anaesthetics; beta-mimetics; MgSO4 
Tissue Retained placenta/membranes 
Abnormal placenta-
succinturiate /accessory lobe 
Incomplete placenta at delivery,  
esp. < 24weeks: Previous uterine surgery; 
Abnormal placenta on ultrasound 
Trauma  Cervical/vaginal/perineal tears Precipitous delivery; manipulations at 
delivery 
Operative delivery; Episiotomy  
 Extended tear at CS Malposition; Fetal manipulation, e.g., 
version of second twin; Deep engagement 
 Uterine rupture Previous uterine surgery 
 Uterine inversion High parity; Fundal placenta 
Excessive traction of cord 
Thrombin Pre-existing clotting 
abnormality 
e.g., hemophilia/ vWD/ 
 
History of coagulopathy/liver disease 
 
 Acquired in pregnancy 
ITP; PET with 
thrombocytopenia (HELLP); 
DIC from PET, IUD, abruption, 
AFE, severe infection. 
 
High BP, bruising 
Fetal death 
Fever, raised WCC 
APH, sudden collapse 
 Dilutional coagulopathy from 
massive transfusions 
 
 Anticoagulation  History of DVT/PE; Aspirin, heparin 
 
 
PPH: postpartum haemorrhage; SROM: spontaneous rupture of membranes; CS: Caesarean section; vWD: von 
Willebrand’s disease; ITP: idiopathic thrombocytopenic purpura; BP: blood pressure; PET: preeclampsia; WCC: white 
cell count; HELLP:  hemolysis, elevated liver enzymes, and low platelets; APH: antepartum haemorrhage; DIC: 
disseminated intravascular coagulation; IUD: intrauterine death; AFE: amniotic fluid embolism; DVT/PE: deep vein 
thrombosis/pulmonary embolism. 
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Identifying exact causes of severe haemorrhage may be challenging in the presence of 
multiple causes or clinically unrecognised or undocumented causes. Different etiologies may 
have common risk factors. This is especially true for uterine atony and trauma of the lower 
genital tract being both increased by prolonged labour or macrosomia.   
 
Risk factors are important and should be studied even though up to 2/3 of cases had no 
identifiable risk factors.89 With changes in the obstetric population (e.g., increased mean 
maternal age at childbirth, increasing number of women with complex medical disorders 
becoming pregnant, increasing maternal obesity and macrosomic infants) and advances in 
technology (e.g., assisted reproduction leading to an increased rate of multiple pregnancy, 
increasing caesarean section rates leading to placenta previa and its sequelae), some of these 
risk factors may become more important and others less so, in the future.6,16,71, 86, 90 7 
Grand multiparas were traditionally thought to be at high risk of PPH, but some studies 
suggest that their risk may be no greater than that of women of lower parity.91 
In the past, most cases of intractable PPH followed vaginal delivery and were due to uterine 
atony; however, more recent reports show that more cases are now associated with caesarean 
delivery. Caesarean delivery for placenta previa increased the risk for peripartum 
hysterectomy by 100-fold, with many patients having a diagnosis of placenta accrete.92 
Higher risk for hysterectomy was found for emergency CS at full dilatation due to failed 
progress in labour or failed delivery using instruments.28 Recent audits showed that CS, even 
if planned, was associated with severe postpartum haemorrhage. 93, 94 
The complex interrelation between different risk factors is important to remember when 
determining their independent contribution to severe haemorrhage risk.  
 
Maternal mortality due to severe obstetric haemorrhage
Rapidly progressing hypovolemic shock is the major cause of death from obstetric 
haemorrhage.19,20 Inadequately treated, it can result in prolonged tissue hypoxia and damage 
with consequent release of thromboplastin from damaged tissue, leading to disseminated 
intravascular coagulation (DIC), and finally cardiac failure, where death is imminent.95 The 
risk of mother dying from severe haemorrhage is dependent on her previous health and the 
presence of anemia, but most importantly on the availability of an immediate access to high 
quality emergency obstetric care. Although MMR from haemorrhage has been dramatically 
reduced in the industrialized world, severe obstetric haemorrhage usually ranks among the top 
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three causes of maternal death, along with embolism and hypertension.16, 96, 97  The recent 
Confidential Enquiries into Maternal and Child Health report in the UK concluded that 
suboptimal care was found in 58% of maternal deaths from haemorrhage.16 There were 
questions concerning the most appropriate management of women with placenta percreta. 
There were apparent failures in recognising the signs and symptoms of intra-abdominal 
bleeding, especially after CS.  Failure to assess the clinical picture, underestimating blood 
loss, delayed treatment, lack of multidisciplinary teamwork and failure to seek timely senior 
staff help are some of the issues highlighted in the British report.16  Among maternal deaths 
due to haemorrhage in the USA, placental abruption was the most common  cause, followed 
by lacerations/uterine rupture, uterine atony and coagulopathy.96  Placental abruption was 
associated with MMR of 38.8/100 000 (7 times higher than the overall MMR) in Finland.83 
Capturing maternal deaths statistically is not straightforward, even in high income 
countries.34, 105 Maternal deaths by nature are prone to underreporting due to misclassification 
of causes and the absence of a diagnosis of pregnancy, especially at early gestations. 
Maternal morbidity due to severe obstetric haemorrhage 
Severe obstetric haemorrhage is associated with increased risks for postpartum sepsis, 
29,48,100,101 acute renal failure,102 and anaemia.103 Iron deficiency anaemia is strongly linked 
with postpartum fatigue and depression.104 Many women who needed hysterectomy suffer 
from serious complications related to the operation as injuries to other organs and 
infection.29,47,48,101 Depression can be the consequence of loss of reproductive capacity or 
perceived loss of femininity and cessation of menstruation.105  The UK Obstetric Team 
Surveillance System (UKOSS) showed a rate of peripartum hysterectomy due to haemorrhage 
of 41/100 1000 maternities. This suggests that more than 60 women undergo a peripartum 
hysterectomy for every woman who dies from haemorrhage.28 
Women with severe morbidities suffered from poorer health with statistically significant 
increases in urgent admissions to hospitals, sexual problems, and outpatient visits within 6-12 
months of follow up.106
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AIMS OF THE STUDY 
 
The main purpose of this study was to increase our knowledge of severe obstetric 
haemorrhage, a major maternal complications at childbirth. Shedding the light on the 
epidemiology of severe obstetric haemorrhage in high resource setting with adequate birth 
registration might contribute into reducing maternal mortality and severe morbidity. The 
underlying general research questions were: 
 
  1. What is the proportion and risk factors of severe obstetric haemorrhage in a high resource 
setting and what is the impact of such complication on maternal and perinatal outcome? 
       2. Is there significantly higher risk of severe postpartum haemorrhage at caesarean section 
compared with spontaneous and induced labour onset?    
 
These issues were explored through a series of works designed to address the following 
aims: 
 
1. Determine the proportion, risk factors, causes and maternal outcome of severe obstetric 
haemorrhage. 
2. Determine the role of obstetric procedures as induction and caesarean section on the risk 
of severe postpartum haemorrhage. 
3. Determine the proportion, risk factors and maternal and perinatal outcome of uterine 
rupture after previous caesarean section. 
4. Determine the effect of spontaneous and induced labour compared with repeated elective 
caesarean section on the impact of uterine rupture on maternal and perinatal outcome.  
5. Determine the effect of different induction methods on the risk of uterine rupture after 
previous caesarean section. 
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Components influencing severe obstetric haemorrhage 
The study concentrated on identifying risk factors that might increase the risk of severe 
obstetric haemorrhage. These included demographic, medical, pregnancy and labour variables 
predisposing to or exaggerating the main causes and mechanisms of severe obstetric 
haemorrhage (Figure 2).                                             
 
        
 
  
                                                              
MATERIALS AND METHODS
Data Source: The Medical Birth Registry of Norway (MBRN) 
 
The source of data in this thesis was the Medical Birth Registry of Norway (MBRN). The 
Medical Birth Registry of Norway was established in 1967 for surveillance of perinatal health 
and to establish a basis for epidemiological research.36, 37 It is a complete nationwide registry 
with consecutive registration of all births after 16 weeks of gestation, containing information 
on the mother, her pregnancy and delivery and the neonate. Information is based on three 
elements: 1) a standardised form used during pregnancy by the mother’s physician, 2) 
information given by the mother when admitted to the hospital and 3) information from the 
physician and midwife about the actual delivery and the neonate. Complete ascertainment of 
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births is ensured through linkage of records with the National Population registry run by 
Statistics Norway,  
It is compulsory to notify the MBRN of all births in Norway, and midwives or physicians 
attending the delivery complete a standardized form within seven days after delivery. The 
form contains information on maternal health before and during pregnancy, detailed 
information about delivery and complications occurring intrapartum or postpartum, and also 
information about the newborn (see appendix). Paediatricians complete a standardised form 
for neonates admitted to neonatal intensive care unit (NICU).33, 35 The data of each mother is 
linked through a unique personal number to The Cause of Death Registry in order to detect 
any maternal or perinatal death. For the purpose of the current study, data in the MBRN file 
was additionally linked to Statistics Norway, in order to obtain information on education level 
and mother’s country of birth. 
In response to the MOMS studies, it has been possible since 1999 to use ticked boxes in the 
registration forms when recording severe obstetric haemorrhage and the majority of variables 
included in this study. These variables included the demographic, major medical diseases and 
most complications occurring during pregnancy, labour and postpartum. We believe that this 
change contributes to facilitating case ascertainment.36, 37 The remaining medical diseases and 
surgical procedures such as hysterectomy were identified by using International Classification 
of Diseases, 10th revision (ICD-10),114 and the Norwegian edition of The NOMESCO 
Classification of Surgical Procedures (NCSP) 2006115 respectively. 
Study design 
The studies were all population-based registry studies. We analysed the registered data of 
population based maternity cohorts. The row data file was converted through several syntaxes 
into readable and feasible data for analysis.
Study population: 
The study population in papers I and II comprised all women giving birth after 16 weeks of 
gestation from 1st January 1999 to 31st April 2004 (307 415 mothers). We included 
pregnancies from the 16th week of gestational age as severe haemorrhage can occur due to 
miscarriages and extra uterine pregnancies. The study population in paper III comprised 
18 794 mothers with births 28 weeks gestation after previous CS, from 1st January 1999 to 
30th June 2005. We included births  28 weeks as no ruptures occurred < 28 weeks. Only 
mothers with previous CS were studied as previous CS is the main risk factor of uterine 
rupture in high resource settings.10
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Table 3. Overview of study populations and main variables in papers I–III. 
 Paper I 
 
Paper II Paper III 
Study 
population 
 
307 415 mothers 16 gest. 
weeks  
307 415 mothers 16 gest.  
weeks  
18 794 mothers with previous 
CS 28 gest. weeks 
 
Sub-populations  
 
 - No previous CS = 291604  
- Previous CS = 15 811  
- Repeated elective CS = 5442 
- Emergency prelabour CS = 
1398 
- Trial of labour = 11 954 
 
Study period 
 
January 1999 - April 2004 January 1999 - April 2004 January 1999 - June 2005 
 
Main outcome  
 
Severe obstetric haemorrhage  Severe postpartum 
haemorrhage 
Uterine rupture 
Secondary 
outcome  
 
1. Hysterectomy 
2. ICU admission 
3. Postpartum sepsis 
4. Acute renal failure 
5. Maternal death 
 Maternal outcome 
1. Hysterectomy 
2. Severe PPH 
3. Moderate PPH 
4. General anaesthesia 
Perinatal outcome 
1.Perinatal death 
2. Post hypoxic 
encephalopathy 
3. Severe asphyxia 
4. Other complications 
 
Explanatory 
variables 
 
 Demographic factors 
 von Willebrand’s disease 
 Cardiac disease 
 Anaemia during pregnancy 
 HELLP syndrome 
 Previous CS 
 Multiple pregnancy 
 Induction 
 Prolonged labour 
 Macrosomia 
 Delivery mode: 
  1. Spont. vag. delivery  (ref.) 
  2. Forceps delivery 
  3. Vacuum delivery 
  4. Elective CS 
  5. Emergency CS 
  6. Assisted breech delivery 
 
Onset of labour:  
 1. Spontaneous onset (ref.) 
 2. Induced onset 
 3. Prelabour CS 
 
Mode of delivery 
 1. Prelabour CS (ref.) 
 2. Spontaneous vaginal 
delivery 
 3. Operative vaginal delivery 
 4. Emergency CS after labour 
start  
 
A. All mothers 
 Maternal age 
 Ethnicity 
 Parity 
 Gestational age 
 Start of birth: 
 1. Repeated elective CS (ref.) 
 2. Emergency prelabour CS 
 3. Spont. labour 
 4. Induced labour  
 
B. Attempting trial of labour 
Induction method: 
  1. No induction (ref.) 
  2. Prostaglandin± amniotomy 
  3. Oxytocin± amniotomy 
  4. Prostaglandins+ oxytocin  +   
amniotomy 
  5. Mechanical methods  
 
Confounding 
variables 
 
 Demographic, medical 
diseases, preeclampsia, 
HELLP syndrome, gestational 
diabetes, gestational age,  
multiple pregnancy, 
prolonged labour, 
macrosomia, polyhydramnios, 
intrapartum pyrexia, uterine 
rupture (only for CSs) 
 
Gestational age in B 
CS: Caesarean section; ICU: Intensive care unit; PPH: Postpartum haemorrhage; HELLP syndrome:  haemolysis elevated 
liver enzymes & low platelets; Gest.: gestational ; Spont.: spontaneous; Vag.: vaginal 
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Variables (Table 3) 
Main outcome variables:  
Severe obstetric haemorrhage was defined as a visually estimated blood loss of >1500 ml 
intrapartum and within 24 hours post-partum, or the need for blood transfusion postpartum 
regardless of the amount of blood loss. Blood transfusion was added to the definition so as to 
avoid missing cases when using visual estimation.52, 70 For severe haemorrhage a specific box 
is ticked off by the attending midwife.
Severe postpartum haemorrhage (severe PPH) was defined as severe obstetric haemorrhage, 
excluding haemorrhages due to placenta previa and abruption. 
Uterine rupture was identified through diagnostic code ICD-10: O71.0 (uterine rupture prior 
to labour start) and O71.1 (uterine rupture during labour) in the registration form. The ICD 
coding does not differentiate between complete or incomplete uterine rupture.114
 
Secondary outcome measures
Maternal outcome  
Only the short-term postpartum complications were available. The association between each 
of severe obstetric haemorrhage and uterine rupture with serious maternal outcomes was 
assessed.   
Maternal death:  Maternal death was defined as the death of a woman while pregnant or 
within 42 days of termination of pregnancy, from any cause related to or aggravated by 
pregnancy or its management, excluding accidental or incidental causes.15 
Peripartum hysterectomy: Hysterectomy indicates the severity of estimated outcome measure 
and its impact on the fertility and future health of women.28, 29, 47, 48, 101, 103 
Intensive care unit (ICU) admission: Severe obstetric haemorrhage is the most common 
cause of maternal admission to ICU.116 
Acute renal failure: Is an indicator of serious hypoperfusion, and carries a risk of dialysis and 
renal transplantation.102 
Postpartum sepsis: Is usually increased after severe haemorrhage due to  pre-existing 
infection,70,87,117  or to increased risk of ascending infection following procedures as manual 
removal of placenta or hysterectomy.29, 48,100,101 In addition, increased infection risk is 
associated with anaemia due to reduced immunity.100,104 
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Moderate postpartum haemorrhage:  Moderate PPH was defined as blood loss 500-1500 ml, 
visually estimated within 24 hours postpartum. It was used as an indicator of the seriousness 
of the identified uterine rupture. 
Exposure to general anaesthesia is an indicator of a high grade of urgency required to save 
the mother or the infant. It indicates a catastrophic nature of the outcome measure (uterine 
rupture).
All maternal outcomes studied were identified through ticked boxes, except for acute renal 
failure, and hysterectomy identified through international diagnostic and surgical procedures 
coding.
Perinatal outcome  
We studied perinatal outcomes after uterine rupture. They were categorised into four mutually 
exclusive groups as follows:  
Perinatal deaths, defined as intrapartum fetal deaths  28 weeks gestation, and neonatal 
deaths 7 days after birth, not related to congenital causes. Antepartum stillbirths were 
excluded in the present study since they were not delivery-related. Stillbirths and neonatal 
deaths within 24 hours are recorded directly in the MBRN form. Information on late neonatal 
deaths and infant deaths is obtained through linkage with the Cause of Death Registry in 
Statistics Norway, ensuring ascertainment close to 100%.36, 37      
Severe asphyxia, defined by diagnostic coding ICD-10: P21.0, excluding encephalopathy.  
Post hypoxic encephalopathy -PHE, defined clinically as cerebral irritation, cerebral 
depression, or seizures in the presence of severe asphyxia. There was no specific box 
identifying PHE. Only cerebral irritation, cerebral depression, and seizures were identified 
through ticked boxes. Therefore, a new variable (PHE variable) was computed where both 
severe asphyxia and any of the neurological signs mentioned were present. 
Other complications, defined as any neonatal problem with or without admission to neonatal 
intensive care unit (NICU), excluding perinatal deaths, severe asphyxia, and PHE described 
above.
Explanatory variables
The explanatory and confounding variables for severe obstetric and postpartum haemorrhage 
and uterine rupture each are shown in table 3.
Demographic factors: These comprised maternal age, parity, ethnicity, education level, and 
smoking. Older maternal age is shown to be associated with increased risk of severe obstetric 
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haemorrhages in previous studies.6, 117, 118 Placenta previa, placental abruption and uterine 
rupture significantly increase with older maternal age.119–121 Primiparity is associated with 
uterine atony and perineal trauma due to increased risk of prolonged labour and operative 
deliveries.118,122 Immigrant mothers from non-Western background were associated with 
significantly higher risks for maternal mortality and adverse maternal outcome according to 
several studies.16,123,124  Asian mothers were shown in previous studies to have a higher risk 
for severe haemorrhage.70 Smoking is known to increase placental abruption.120 Education
level was used as an indicator of socioeconomic status.  Low socioeconomic status is 
associated with increased risk for severe obstetric haemorrhage and other adverse maternal 
and perinatal outcomes.6, 16 
Medical factors:  von Willebrand’s disease is the most common inherited blood disorder, and 
is associated with increased risk for severe obstetric haemorrhage due to coagulopathy.125  
Mothers with pre-existent cardiac disease are increasing due to recent advances in surgical 
correction of congenital heart diseases. Mothers with these diseases were shown to have 
increased risk for PPH in a previous study.126 
Pregnancy/labour factors:  Multiple pregnancy increases the risk of severe haemorrhage due 
to uterine overdistension, resulting in uterine atony.6, 70, 86 HELLP syndrome increases the risk 
of coagulopathy and placental abruption.86, 120 Anaemia during pregnancy increases maternal 
decompensation due to small blood reserve.56, 120 Previous CS increases the risk for placenta 
previa, abnormally adherent placenta, and uterine rupture.28, 48, 86-88, 128 Macrosomia increases 
uterine atony by uterine overdistension and uterine exhaustion, in addition to increasing 
genital trauma.70, 87, 90  Induction and, prolonged labour increase both of uterine exhaustion 
and uterine rupture.70, 87, 128 
Mode of delivery: Compared with spontaneous vaginal delivery, operative vaginal delivery 
increases uterine atony and perineal trauma.70, 83, 94,120 Both Emergency CS and elective CS 
increase the risk for uterine atony and surgical haemorrhage. 87, 93, 94,120 
Start of birth was the main explanatory variable in paper II and III.  In paper II, It was 
categorised into three groups: ‘Spontaneous labour onset’, ‘Induced labour onset’ and 
‘Prelabour CS’. The group of ‘prelabour CS’ comprised both elective CS (16 315 mothers) 
and emergency CS performed prior to established labour (6770 mothers). In this paper, we 
focused on determining the risk of severe PPH at prelabour CS with no underlying placenta 
previa or placental abruption, regardless of the emergency element included in the procedure.  
Start of birth in paper III was categorised into four groups: ‘Elective prelabour CS’ 
(reference), defined as planned CS performed before onset of labour, ‘Emergency prelabour 
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CS’, defined as emergency CS before onset of labour, ‘Spontaneous labour onset’, and 
‘Induced labour onset’.  Information about birth start was complete. 
Induction method:  Categorised into: ‘No induction: spontaneous labour onset’ (reference), 
induction by ‘Prostaglandins with or without amniotomy’, ‘Prostaglandins, amniotomy & 
oxytocin’, ‘Oxytocin with or without amniotomy’, and ‘mechanical methods’ defined as 
amniotomy alone or other non-medical induction methods.    
Gestational age:  Calculated by ultrasound at 18 weeks and categorized into: ‘24–36’, ‘37–
40’ (reference), and ‘41’ weeks. 
 
All variables were identified through ticked boxes except for von Willebrand’s disease. As 
they are not routinely recorded in the MBRN registration form, variables such as previous 
obstetric haemorrhage, prophylactic use of oxytocin in third stage, maternal body mass index, 
number of previous CSs, and indications of previous CS were not available 
Statistical analyses
Proportion of the outcome measure 
The occurrence measure of an outcome in perinatal and maternity cohorts can be expressed by 
the terms: risk, cumulative incidence, or proportion.129 We will be using the term 
‘‘proportion’’ to describe the occurrence measure of the outcome. This term was used to 
describe the occurrence of uterine rupture in paper III. Unfortunately, we used the term 
‘‘prevalence’’ in paper I and II. ‘‘Prevalence’’ was frequently used to describe severe 
obstetric haemorrhage in previous studies in international obstetric journals.  As severe 
obstetric haemorrhage is an acute morbidity and not a chronic disease, we believe that it is 
incorrect to use ‘‘prevalence’’, and therefore, we will be using ‘‘proportion’’ in this thesis. 
Frequency analysis and cross tabulations were used to measure the proportion of primary and 
secondary outcomes. The proportions of different causes of severe obstetric haemorrhage 
were calculated using cross tabulations. 
Choosing the explanatory variables in analytic models 
We studied the train of events where risk factors (the starters) lead to the different causes of 
severe obstetric haemorrhage (Figure 2).  In doing that, the explanatory variables were chosen 
based on their clinical relevance and evidence from previous studies.6,16, 28, 48, 56,70, 83, 86-88, 93, 94, 
117–128 Risk factors might start prior to pregnancy as demographic factors, pre existing medical 
diseases, or previous obstetric history. They might start during pregnancy, as multiple 
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pregnancy, and might as well start during labour, as induction or prolonged labour or even 
later at delivery. We have tried different models including explanatory variables at different 
levels. Medical pre-existing variables were controlled for demographic factors as age, parity, 
and ethnicity in one model. Several models were tried so as to analyse pregnancy 
complications controlled for relevant confounders prior to pregnancy. Other models were 
tried to analyse labour variables, controlled for confounders prior to labour. This process of 
analysing was continued until we reached the final model where delivery mode variable was 
the main explanatory variable. The mode of delivery variable was controlled for confounders 
prior to delivery. Confounders included clinically relevant demographic, medical, pregnancy 
and labour risk factors that preceded the delivery (Figure 3).  
 
We avoided using variables that constitute parts of the outcome measure (severe obstetric 
haemorrhage) as early gestational age and manual removal of placenta.  Early gestational age 
was not included as a risk factor although it is known to be associated with severe 
haemorrhage. This association is in a major part due to placenta previa or abruption, causing 
severe haemorrhage as well as precipitating to premature delivery. Manual removal of the 
placenta was not included either as it is a known consequence of retention of placenta, another 
main cause of severe haemorrhage. Shoulder dystocia was not included in the model as it 
followed the delivery mode.  Even when considered as the actual explanatory variable in a 
separate model, shoulder dystocia lost its significance after adjusting to macrosomia.    
All variables were handled as categorical. The category with the lowest risk or the largest 
number of mothers included was used as the reference group in logistic regression analysis.  
In paper III , we limited the number of explanatory variables to avoid overfitting or inflation 
of the model, as the events (uterine rupture) were of small size due to rarity.130 
Stratification 
Stratification is an important analytical approach. It involves preparing separate analyses 
within subgroups of the study population. This allows one to examine the relationship 
between the outcome and the explanatory variables in subsets in which the relationship may 
be simpler and clearer.131 
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          Figure 3. Interrelation between risk factors of severe obstetric haemorrhage                
 
The association between the delivery mode for example and severe obstetric haemorrhage 
was assessed while stratified into different groups with or without other explanatory variables. 
This stratification revealed no interaction between the explanatory variables but showed the 
presence of confounding. A covariate was considered as a confounder when its addition to the 
model, resulted in a change of the estimate (odds ratio) of at least > 10%.132 These tests are 
not shown in the papers, but were performed as preliminary steps to design the final model. 
Univariate and bivariate analysis 
To examine the risk of outcome related to certain explanatory variables, we started first with 
cross tabulations/logistic regressions of each explanatory variable and the main outcome. This 
reveled the absolute risk of the outcome in the group exposed to the studied variable, 
expressed in percentage (univariate analysis), and the relative risk of the same variable, 
expressed in odds ratio and 95% confidence interval (bivariate analyisis). The Chi-square test 
was used for hypothesis testing. The P-value was interpreted as the probability of observing 
our data when the null hypothesis is true.133 The level of significance was P<0.05. In 
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interpretation, the emphasis was on confidence intervals rather than p-value, as confidence 
interval reflects the precision of the results more than P-value. Fishers exact test was used to 
assess the significance when the size of the outcome (the events) was small as in paper III 
studying uterine rupture and its serious maternal and perinatal outcomes. 
The relative risk after bivariate analysis describes the effect of the risk factor studied, but does 
not determine if this effect is real or specific as it does not adjust for the effects of other 
interelated risk factors (Confounding).    
 
Multivariate analysis
Multiple logistic regressions were used as many risk factors of obstetric morbidities are inter-
related (Figure 3). Multiple logistic regressions are used in order to assess the relationship 
between the explanatory variables and the dichotomous outcome, allowing for adjustment for 
other independent variables (confounding).134 We used multiple logistic regressions to control 
for these confounding factors to avoid a 'false positive' conclusion that the dependent 
variables are in a causal relationship with the independent variable (a spurious relationship). 
We chose the confounding variables that satisfied all these following three criteria in each 
model:  (1) it must have an association with the outcome,  (2) it must be associated with the 
exposure,  and (3) it must not be an effect of the exposure; this also means that it may not be 
part of the causal pathway. We tried to avoid adjusting for highly correlated variables (i.e. 
avoiding the problem of multicollinearity).135 In the presence of multicollinearity, the estimate 
of one variable's impact on the outcome, while controlling for the others, tends to be less 
precise than if the predictors in the model were less correlated with one another.  
The factors of clinical relevance, and factors with level of significance of P<0.20 were taken 
into account, adding one variable at a time in two variables models first.  The effect is based 
on the change in the odds ratio calculated and the 95% confidence intervals and the p-value 
(<0.05). The fitness of the model was assessed using Hosmer-Lameshow goodness of the fit 
in logistic regression in SPSS programme, version 15.  
In paper III on uterine rupture, the influence of single observations on the fit of the model was 
tested for each coefficient in the final models by using the influence test DfBeta (Difference 
in Beta values) in the logistic regression in SPSS.136 
Ethical Consideration 
The study was approved by the Regional Ethical Committee for Medical Research, The 
Norwegian Data Inspectorate, and the Norwegian Directorate of Health.
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SUMMARY OF PAPERS 
Paper I: Prevalence and Risk factors of Severe Obstetric Haemorrhage 
Objective: To determine the proportion, causes, risk factors and maternal outcome of severe 
obstetric haemorrhage in all pregnant women giving birth after 16 weeks in 1999-2004 
(N=307 415). 
Main outcome measure: Severe obstetric haemorrhage (blood loss of > 1500 ml, or blood 
transfusion). 
Methods: Cross-tabulation and multiple logistic regressions were used to determine 
proportion, causes, risk factors, and acute maternal complications of severe obstetric 
haemorrhage. 
Results: Severe obstetric haemorrhage occurred in 1.1% of mothers. Uterine atony was the 
main identified cause (30.1%), while no cause was identified in 30.8% of cases (Figure 4).  
The risk factors with the highest odds for severe haemorrhage were emergency CS, von 
Willebrand’s disease, elective CS, multiple pregnancy, anemia, macrosomia and HELLP 
syndrome. Other risk factors included operative vaginal delivery, older age, South East Asian 
origin, induction, previous CS and prolonged labour. Severe haemorrhage was associated with 
higher risks for maternal death, hysterectomy, ICU admission, postpartum sepsis and acute 
renal failure.  
Figure 4. Causes of severe obstetric haemorrhage
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Conclusion: A relatively high rate of severe obstetric haemorrhage was detected, with a large 
percentage of unidentified causes. Many of the significant risk factors can be influenced by 
reviewing labour management and protocols.  
Paper II: Effects of Onset of Labor and Mode of Delivery on Severe Postpartum 
Hemorrhage
Objective: To study the impact of labour onset and delivery mode on the risk of severe 
postpartum haemorrhage in total mothers of 307 415, and in the two subgroups of mothers 
without previous CS (291 604), and mothers with previous CS (15 811). 
Main outcome measure: severe postpartum haemorrhage  
Method: The association between severe postpartum haemorrhage and labour onset was 
analyzed using three logistic regression models: (1) Spontaneous labour onset (reference) 
versus Induced labour onset, (2) Spontaneous labour onset (reference) versus Prelabour CS, 
and (3) Induced labour onset (reference) versus Prelabour CS. The association between severe 
postpartum haemorrhage and mode of delivery was analysed using four logistic regression 
models with prelabour CS as reference. Finally, the association between severe postpartum 
haemorrhage and delivery mode after both spontaneous and induced labour was analyzed 
using logistic regression in three separate groups: 1. primiparas, 2. multiparas without 
previous CS, and 3. mothers with previous CS.  Cross tabulations were used to identify causes 
of severe postpartum haemorrhage at different delivery modes. 
Results: Compared with spontaneous labour, haemorrhage risk was higher for induction (OR: 
1.71; 95% CI: 1.56– 1.88) and prelabour CS (OR: 2.05, 95% CI: 1.84–2.29). The risk was 
55% higher for emergency CS, and halved for vaginal deliveries (OR: 0.48; 95% CI: 0.43-
0.53), compared with prelabour CS (Figure 5). The highest risk was observed for emergency 
CS after induction in mothers with previous CS (OR: 6.57; 95% CI: 4.25–10.13), compared 
with spontaneous vaginal delivery in mothers without previous CS.  Mothers with previous 
CS had significantly higher proportion of severe PPH (2.1 %), versus mothers without 
previous CS (1%).  The largest percentage of unidentified causes was found in mothers with 
severe PPH after CS (more than 60%). 
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Figure 5. Severe haemorrhage percentage at different delivery modes
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Conclusion: Induction and prelabour CS should be practiced with caution due to the 
increased risk of severe postpartum haemorrhage. Prelabour CS might be a better option if the 
probability of emergency CS is high. Large-scale prospective studies are needed to 
objectively document the amount and precise causes of blood loss at CS. 
 
 
Paper III: Uterine Rupture after Previous Caesarean Section 
 
Objective: To determine the risk factors, proportion, and maternal and perinatal outcomes of 
uterine rupture  among mothers giving birth  28 weeks subsequent to previous CS (N= 
18794) during six years.  A further aim was to study the impact of different induction 
methods on uterine rupture. 
Main outcome measure: Uterine rupture. 
Method: The association between different explanatory variables and uterine rupture risk was 
assessed using cross tabulations and multiple logistic regressions.  
The medical records of eleven mothers with uterine ruptures at prelabour CS were studied. 
The association between uterine rupture and serious maternal and perinatal outcomes was 
assessed in all mothers, in mothers having prelabour CS and mothers attempting trial of 
labour (TOL).  
 Results: A total of 94 uterine ruptures were identified (5.0/1000 mothers). Compared with 
elective prelabour CS, the odds of rupture increased for emergency prelabour CS (OR: 8.63; 
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95% CI: 2.6–28.0), spontaneous labour (OR: 6.65; 95% CI: 2.4–18.6) and induced labour 
(OR: 12.60; 95% CI: 4.4–36.4). The odds were increased for maternal age 40 vs. <30 years 
(OR: 2.48; 95% CI: 1.1–5.5), non-Western origin (OR: 2.87; 95% CI: 1.8–4.7) and gestational 
age 41 weeks vs. 37-40 (OR: 1.73; 95% CI: 1.1–2.7). Uterine rupture after TOL significantly 
increased severe postpartum haemorrhage (OR: 8.51; 95% CI: 4.6–15.1), general anaesthesia 
exposure (OR: 14.20; 95% CI: 9.1–22.2), hysterectomy (OR: 51.36; 95% CI: 13.6–193.4), 
and serious perinatal outcome (OR: 24.51 (95% CI: 11.9–51.9). The highest percentages of 
rupture-related serious maternal and perinatal outcome were observed when ruptures followed 
TOL (Figure 6). Serious perinatal outcomes were highest when ruptures followed induction of 
labour. Induction by prostaglandins significantly increased the odds for uterine rupture 
compared with spontaneous labour (OR: 2.72; 95% CI: 1.6–4.7). Prelabour ruptures were 
detected after latent uterine activity or abdominal pain among mothers with multiple or 
longitudinal uterine scars.    
Figure 6. Proportion of rupture-related maternal and perinatal outcome at 
different birth starts
0
0
0
100
488
38
0
250
100
0
0
400
150
111
475
0 100 200 300 400 500 600
Moderate
haemorrhage after
rupture
Severe haemorrhage
after rupture
Hysterectomy after
rupture
General anaesthesia
after rupture 
Serious perinatal
outcome after rupture
Per/1000
Trial of labour
Emergency
prelabour CS
Elective CS
Conclusion: Trial of labour carried greater risk and graver outcome of uterine rupture vs. 
elective repeated CS, although absolute risks were low. A review of labour management and 
induction protocol is needed. 
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DISCUSSION 
Main results 
Severe obstetric haemorrhage occurred in 1.1% of all mothers. Uterine atony was the main 
identified cause, representing 30%, while no cause was identified in almost one third of the 
cases. Cases of Severe haemorrhage at CS had in a major part unidentified cause.  The mode 
of delivery was the most important risk factor, especially emergency CS, followed by elective 
CS when compared with spontaneous vaginal deliveries. Other important risk factors included 
multiple pregnancy, von Willebrand’s disease, HELLP syndrome, anaemia during pregnancy 
and macrosomia. Mothers with severe obstetric haemorrhage had significantly higher risk for 
severe postpartum morbidity as peripartum hysterectomy and maternal mortality. 
 
Prelabour CS and induction significantly increased the risk for severe postpartum 
haemorrhage (PPH) compared with spontaneous labour onset in mothers with or without 
previous CS, even after adjusting for underlying indications. There was no significant 
difference in severe PPH risk between prelabour CS and induction. Vaginal deliveries halved 
the risk of severe PPH compared with prelabour CS even in mothers with previous CS. 
Operative vaginal deliveries after induction significantly increased haemorrhage risk in 
primiparas. Emergency CS after labour onset had the highest risk for severe PPH in all 
mothers, but especially after induction in women with previous CS. Thus, elective CS might 
be a better option among mothers with previous CS if the probability for emergency CS after 
trial of labour is high.   
 
Uterine rupture occurred in 5/1000 of all mothers with previous CS. The highest risk was for 
induced labour and emergency prelabour CS, while the lowest risk was for repeated elective 
CS. Uterine rupture was significantly associated with both severe and moderate PPH, 
peripartum hysterectomy, exposure to general anaesthesia, and serious perinatal outcome, but 
only if occurring after trial of labour. Induction by prostaglandins carried significantly 
greatest odds for uterine rupture. Prelabour ruptures were detected after latent uterine activity 
or after abdominal pain in mothers with multiple or longitudinal uterine scars. Older age and 
ethnicity were significant risk factors for both severe obstetric haemorrhage and uterine 
rupture.   
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Methodological consideration 
Methodological questions have been discussed in the individual papers. The aim of this 
section is to summarize the methodological limitations and advantages of the study, and to 
assess to what extent the limitations may have influenced the results. The interpretation of the 
results obtained will be then discussed. 
Advantages and limitations of the study 
The methodological strength of the current study is the population-based design including a 
large sample of mothers. This gives the opportunity to study the total population without 
selection bias. It allows also for studying rare events like uterine rupture, and severe 
complication as severe obstetric haemorrhage. The large sample size provided sufficient 
power to estimate associations in subgroups of women, even for small effects. Information on 
many covariates contributed to controlling for many potentially confounding variables.  An 
important advantage in our population is the presence of a high rate of trial of labour after 
previous CS (around 61%).137 This allowed us to study the association of different onsets of 
labour and modes of deliveries with the risk of severe haemorrhage and uterine rupture after 
previous CS. 
The disadvantages lie in lack of specific details of labour and induction due to the nature of 
register, and inherent inadequate registration of diagnosis and/or procedures. Details of 
obstetric history as previous obstetric haemorrhage or previous retention of placenta, etc. was 
not available through the data file used in this study. This could be achieved if we had a sib 
ship file that follows the different pregnancies of each mother. Case records would provide us 
with information not available in the registry, such as the duration of labour, the dosage of 
specific induction agents, or causes of haemorrhage at CS, etc. Information bias could be 
reduced in this study by using clearer definitions of variables, better measuring methods, 
standardized procedures and quality control. Certain variables like prolonged labour need a 
clearer definition. Ticked boxes should be used to record uterine rupture, placenta accreta and 
hysterectomy. Visual estimation of blood loss should be standardised in order to get valid 
results. Quality control can be achieved by performing validity study of MBRN registration of 
severe obstetric haemorrhage and uterine rupture. MBRN has generally adequately high 
registration quality as documented by several validity studies.138–143 
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Do the results of this study truthfully reflect the reality? To answer this question, it is 
necessary to assess the possible sources of error. In principle, the reliability of the 
measurement may be reduced due to random error, while the validity of the results may be 
reduced due to systematic error (bias).  
Reliability consideration: Random errors 
Random error is due to chance or insufficient information, and leads to loss of precision. 
Precision in an estimator (i.e. an odds ratio OR) can be improved by increasing the sample 
size or by increasing the efficiency with which information on the individual level is obtained. 
In epidemiological studies, the principle way to increase precision is usually by increasing the 
sample size.144 Our study sample covering all maternities over a five years period, was large 
enough for analysis in paper I & II. This was also reflected in the narrow confidence intervals 
achieved indicating precision.  However, the sample of mothers with previous CS over a six 
years period was not large enough to measure the association between exposures and the rare 
event of uterine rupture with high a high degree of precision, as seen in the wide confidence 
intervals of the odds ratios. This was particularly the case when measuring the association 
between uterine rupture (only 94 rupture) and the secondary maternal and perinatal outcomes, 
and also between specific induction methods and uterine rupture. 
Validity considerations (bias) 
The validity of any epidemiological study is influenced by systematic error (bias).  We can 
say that our study was valid if our design and methods provided unbiased estimates of the 
parameters studied. 
 Sources of systematic errors (bias) include selection / sample bias, information bias and 
confounding.144 
 
1. Selection bias 
Selection bias occurs as a result of non representative samples, often resulting from the use of 
convenience samples and other non-probability methods.  As our sample size represents the 
total population of pregnant women, selection bias does not affect the internal validity of this 
study. However, selection bias may be a problem concerning the external validity of the study 
if the results are generalized beyond the target population. The pregnant population in 
Norway may not share the general demographic, genetic, and management factors as the 
pregnant populations in other high resource settings as for example in the UK.  
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2. Information bias 
There is a probable information bias in this study as it is based on population registry data. 
Information bias is due to misclassification of study factors: Either of the exposure 
/explanatory variable), of the outcome (severe obstetric haemorrhage/ uterine rupture), or of 
the confounding variables. As the old saying goes, the quality of the study is limited by the 
quality of the measurements (“garbage in, garbage out”).  
Briefly, information bias can be either differential or non-differential.144 The former is a 
systematic misclassification occurring at different rates in the groups being compared, 
resulting in a particular group or groups of individuals having a greater chance of being 
misclassified than do others in the sample. This is of concern since it leads to either inflated or 
deflated estimates of associations. Non-differential misclassification is random 
misclassification where all individuals for whom we have the data are equally likely to be 
misclassified. In general, the non-differential misclassification is preferred, as the resulting 
bias will bring estimation toward the null hypothesis. These errors tend to deflate associations 
with the outcome in the case of dichotomous exposures.  
 As the details of each mother are routinely registered by birth attendant within very short 
time postpartum, systemic misclassification due to recall bias or differential recording of the 
events would be uncommon in this study.  In contrast, non- differential misclassification tends 
to be more common in the MBRN, leading generally to deflated estimations in this study.
a. Information bias in explanatory variables 
In general, the explanatory variables that are identified through ticked boxes are less 
frequently to be misclassified than those identified through diagnostic coding as demonstrated 
in a validating study of the Swedish Birth Registry.145 
The majority of explanatory variables, including demographic, pregnancy and labour factors, 
were identified through ticked boxes in this study. 
 Maternal age is likely to have essentially no errors while parity and birth weight may have a 
small amount of error that is essentially negligible due to the large size of the sample. 
Education level, though identified through ticked boxes, was missing in a good proportion of 
mothers. This might have resulted in lack of association with severe obstetric haemorrhage. 
Delivery modes and onset of labour tends to be most accurate as they are straightforward and 
registered within short time after delivery.  However, it is difficult to use a unified concrete 
definition of prolonged labour. The definition varies due to differences in subjective 
individual assessments as well as maternal factors like parity and use of epidural anaesthesia. 
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Moreover, there is no specific box for prolonged first stage or prolonged second stage of 
labour in the registration form. Misclassification can occur when documenting the specific 
induction method, especially if induction was followed by augmentation with oxytocin. These 
errors might have resulted in underestimated associations with severe obstetric haemorrhage 
or uterine rupture. The validating study from the Swedish registry found generally the same 
errors that we are concerned with such as using the codes instead of ticked boxes, inadequate 
transfer of information from the case records, misclassified clinical diagnosis.145 On the other 
hand, even with errors occurring at different stages of registration, the data set is so large, that 
it compensates for relatively small margin of errors. 
 
b. Information bias in outcome variables 
An Australian study assessing the quality of data based on hospital discharge registry found 
that when compared with a recorded diagnosis of postpartum haemorrhage (PPH) in the 
medical records, the discharge data had a sensitivity of 73.8% and a positive predictive value 
(PPV) of 83.9%. However, when defined by either a recorded diagnosis of PPH or amount of 
blood loss, the hospital discharge data had a sensitivity of 50.3% and PPV of 91.0%. The 
findings of this validating study imply that it is important to be aware of the definition used to 
code the diagnosis or procedure as opposed to the clinical definition.146 This strengthens the 
validity of our estimations in this study as we used the amount of blood loss in the recorded 
definition as well as the clinical definition. The amount of blood loss however could be 
misclassified clinically as visual estimation underestimates the actual amount. We tried to 
minimise this underestimation of blood loss by adding the need for blood transfusion in the 
definition.   
Sensitivities in the Australian study ranged from 28.3% for the reporting of peripartum 
hysterectomies to 100% for placenta previa and repair of cervical laceration or perineal 
lacerations. Misclassification of hysterectomy was also found in our study. In paper I, we 
reported only eight hysterectomies in the target population where we related this to 
underreporting resulting from using procedure codes.  These figures were revised while 
writing paper III and we found that one of the hysterectomy codes was not used while 
calculating hysterectomies. Being used, this resulted in increasing hysterectomies to 47 (40 in 
mothers with obstetric haemorrhage). The calculated increased risk of hysterectomy after 
severe obstetric haemorrhage should accordingly be 500-fold instead of 115-fold. 
 One of the challenges in identifying causes of obstetric haemorrhage through registered data 
worldwide is the lack of separate ICD codes for specific causes like the different types of 
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placenta accrete/percreta/increta. In addition, there are no separate codes for atonic PPH and 
PPH immediately following childbirth due to other causes. In this study, uterine atony, 
placenta previa, placental abruption and retained placenta were identified through specific 
ticked boxes, ensuring better reporting.  
Uterine rupture, however was identified through international coding, not differentiating 
between incomplete and complete ruptures (symptomatic ruptures). Mixing would most 
probably result in deflated association between risk factors and actual complete ruptures. Risk 
factors for complete ruptures might be different from those affecting dehiscences. This 
problem could be avoided if ticked boxed were used for each of complete and incomplete 
rupture. We discussed this problem in details in paper III. Post hypoxic encephalopathy and 
severe asphyxia are also likely to be underreported.  
3. Confounding  
 Confounding (from the Latin confundere: to mix together) is a systematic error in which lack 
of control for a third variable may distort an association between an exposure and an outcome. 
All efforts were focused on minimising multicollinearity by avoiding adjusting for 
intermediate events or events in the casual pathway between exposure variable (delivery 
mode) and the outcome measure (severe haemorrhage).  
Residual confounding means the presence of confounding variables that were not controlled 
in models measuring association parameter.144 Previous obstetric haemorrhage and maternal 
obesity were not available, and thus their contribution into haemorrhage risk could not be 
measured. Confounding variables as multiple previous CS, indication of previous CS, and 
other types of uterine scars were not available when measuring the effect of start of birth on 
uterine rupture. This issue is of great importance especially that we found such risk factors in 
mothers with prelabour ruptures through studying their case records. Information on cervical 
ripeness/duration of induction was not available. Therefore their confounding on induction 
method could not be controlled. 
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Interpretation of the results 
The proportion of severe obstetric haemorrhage 
The proportion of severe obstetric haemorrhage of 11.38/1000 (95% CI: 11.3-11.5)147 was 
relatively higher than other studies in high resource settings (Table 4). MOMS-B study used 
the same clinical definition of blood loss>1500 ml or need for blood transfusion as ours, but 
only from 24 weeks gestations, covering only certain regions in each European country 
included in one year interval.8 The proportion of severe obstetric haemorrhage in each country 
involved was lower than our figure. The highest proportions of 8.8/1000 was found in Finland 
(65% of all maternities), followed by 6.8/1000 in UK (only South East Thames region). These 
figures are still lower than ours as was discussed in paper I. This could be partly explained by 
our larger denominator of gestations after 16 weeks, in addition to including cases of placenta 
previa and abruption. However, even if we removed these cases (total of 221), we are still 
having a proportion of 10/1000. 
 Studies from Canada and USA had very low figures as they used stricter inclusion criteria of 
severe haemorrhage (ICU admission/ hysterectomy).63–67  
There are several probabilities underlying our relatively higher proportion of severe 
haemorrhage compared with the figures reported in MOMS study. These include the 
following: 1. Norway has a real higher proportion of severe obstetric haemorrhage than these 
countries, 2. Better ascertainment of our study, or 3. We have overestimated the actual 
proportion of severe haemorrhage.   
We might have better case ascertainment than other studies as we used data of the total 
population through five years (307 415 mothers), and not only selected regions in limited 
time. In spite of generally narrow confidence intervals in previous studies (Table 4) our 
confidence interval is even much narrower, reflecting higher precision of our estimate due to 
larger sample size.147 
Norway participated in MOMS study, with data from two hospitals in Oslo. Mothers referred 
to these hospitals with severe complications from areas outside Oslo were excluded. This 
might have contributed to the low reported rate of severe haemorrhage of 2.7/1000 among a 
sample of 3010 mothers.8 Eggebø et al performed a hospital-based study in Stavanger 
University Hospital over three years, and reported a higher proportion of severe haemorrhage 
of 8.5/1000.148, 149 This might be due to a larger representative sample of mothers in this study 
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or a restricted use of prophylactic oxytocin in the third stage of labour during a  certain period 
covered by this study . 
 
 
Table 4. Severe obstetric haemorrhage reported in different studies 
Author/Country Study years No. of 
deliveries 
Proportion/1000  Definition criteria 
Basket and Sternadel,63 Canada 1980-1993   76 119  0.16  (0.1–0.2) ICU admission 
Lapinsky et al,64 Canada 1990-1994   25 000  0.4   (0.3–0.5) ICU admission 
Mahutte et al65 Canada 1991-1997   44 340  0.8   (0.7-0.9)  ICU admission 
Monaco et al,66 USA  1983-1999   15 323  0.2  ( 0.1–0.3) ICU admission 
Murphy and Charlette,67 USA 2002-2002   51 576  0.2   (0.16–0.23) ICU admission 
Hazelgrove et al,68 UK 1994-1996 122 850  0.6  (0.56–0.64) ICU admission 
Bewley and Creighton,69 UK 1991-1992     6039  2.3  (1.9–2.7) ICU admission 
Brace et al,7 Scotland 2004-2004   51 165  1.9  (1.8–2.0) Blood loss  2500 ml, 
 or blood transfusion 
>5 units, or treatment 
for coagulopathy 
Brace et al,25 Scotland 2003-2005 155 820  3.7 (3.4–4.0) Blood loss  2500 ml, 
 or blood transfusion 
>5 units, or treatment 
for coagulopathy 
Zhang et al (MOMS-B), 8 
Europe  
1995-1998 182 734  4.6 (4.3–5.0) Blood loss  1500ml, 
or   transfusion 
(blood/expanders)  
     1. Austria  9/1996-8/1997    6022  0.7 (0.2–1.8)  
     2. Belgium 1/1996-12/1996  17042  6.0 (5.0–7.4)  
     3. Finland  5/1996-9/1996  17249  8.8 (7.5–10.4)  
     4. France 1/1995-12/1995  71909  3.1 (2.7–3.5)  
     5. Hungary 1/1995-12/1995 13 667  1.6 (1.0–2.5)  
     6. Ireland 1/1996-12/1996    1800  1.1 (0.2–4.5)  
     7. Italy 3/1996-2/1997    3170  1.3 (0.4–3.5)  
     8. Norway (Oslo) 1/1995-12/1995    3010  2.7 (1.2–5.2)  
     9. UK 1/1997-2/1998  48865  6.8 (6.1–7.5)  
Eggebø and  
Gjessing,148,149Norway 
1/1997-1/2000  12659  8.5 (8.0–8.9) Blood loss > 1500 ml 
 
Al-Zirqi et al,147 Norway, 2008 1/1999-3/2004 307415 11.4 (11.3–11.5) Blood loss > 1500ml, 
or need of transfusion. 
       ICU: intensive care unit 
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The data used in our present study is routinely registered according to Norwegian law. We are 
not dependent on response rate or motivation of participants, and thus selection bias is 
avoided. We therefore hypothesise that using a similar population- based study would 
increase the proportion of severe haemorrhage in other settings, and allow the results from 
different countries to be comparable. 
 
Could it be possible that we have in fact a higher proportion of severe obstetric haemorrhage 
than other countries? If this was true, this might be explained by different characteristics of 
our population, or different management or procedures. Generally, Our CS rate of 17.1% is 
lower than other countries with similar resources such as 30.8% in USA,150  24% in UK151, 
and 38.3%in Italy.152 The global increase in mean maternal age and maternal obesity is also 
seen in Norway, but the figures in our population are not higher than in other countries.153, 154 
The induction and multiple pregnancy rates are increasing in our population,85 as in other 
populations.158  Our population is more homogenous than other populations with higher 
percentages of immigrants with higher risk for adverse maternal outcome.155 We can not omit, 
however the possibility of an underlying genetic predisposition to haemorrhage in Norwegian 
mothers. 
 
Inadequate management of the third stage might be contributing to the high proportion of 
severe haemorrhage in our study.  According to a European survey, 81 among 83.6% of 
responding maternity units in Norway, only 11% were using active management of third stage 
as FIGO recommended. In addition only 39% of these units used controlled cord traction, 
while only 72% used oxytocin as prophylaxis. However, this was not only the case for 
Norway, as the survey showing that only 3–20% of  the responding obstetric units  in Austria, 
Denmark, Finland, France, Hungary, Italy, and Portugal actively managed the third stage. 
Among 68.4% responding units in the UK, prophylactic oxytocin and controlled cord traction 
were used in 96% and 87% of these units respectively. However, severe haemorrhage was 
reported to be much more frequent in the South East Thames region in UK (6.8/1000) than in 
upper Austria (0.7/1000).8 In Austria, oxytocin prophylaxis and controlled cord traction were 
used in only 52% and 21% of the units respectively. However only 31.7% of units in Austria 
responded to the survey.81 It is important to mention that the Norwegian study by Eggebø et al 
demonstrated that severe haemorrhage increased when prophylactic use of Oxytocin was 
restricted during a certain period.148 
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In Norway, manual removal of retained placenta is not performed in the majority of units 
before 60 minutes after birth. One may speculate whether this may have contributed to our 
relatively high proportion. However, the same policy is practiced in the Netherlands, 
Denmark and Finland.156 The majority of units in France and Belgium remove the placenta at 
or before 30 minutes, but they do not have the lowest rates of severe haemorrhage (Table 4).  
Moreover, there is no evidence that artificial reduction of the length of the third stage by 
manually removing placentas that have not been spontaneously expelled will reduce the risk 
of PPH. Retained placenta may be the consequence of an impaired uterine contractility that 
will also lead to PPH. In that case, a long third stage would be a more risk marker than a 
cause of PPH.  
 As discussed earlier in introduction, the different protocols regarding blood transfusion and 
other procedures contribute to the variation in reported rates of severe haemorrhage despite 
using the same definition. 
  
The third probability behind our figure lies in an overestimation, or false positive cases. This 
might be due to misclassification in registration. This is highly unlikely as discussed in 
methodology that such random misclassification would result in underestimation rather than 
overestimation. Measuring haemorrhage depending on visual estimation would most likely 
result in underestimation. We do not think that adding blood transfusion is a reason of 
overestimation, as the policy of blood transfusion is very strict.  
Using a broad definition may capture larger number of cases at an earlier stage in the train of 
events prior to near miss or death. If we included only those with hysterectomy, or those 
admitted to ICU, the proportion of severe haemorrhage would be 0.12/1000 and 0.8/1000 
respectively. This is as low as in studies using strict criteria (Table 4). Using ICU admission 
criteria would capture only 7% of mothers reported with severe haemorrhage in our study.   
The seriousness of severe obstetric haemorrhage would be better assessed in our population if 
we could identify mothers with blood loss >2500 ml, and if we knew the number of blood 
units transfused. This could contribute to establishing a scoring system of severe obstetric 
haemorrhage prior to hysterectomy or other serious outcomes. We can thus estimate the 
association of certain risk factors with more serious degree of severe haemorrhage.  
Causes of severe obstetric haemorrhage   
The finding that uterine atony was the main cause of severe haemorrhage is consistent with 
the reports in the literature.81 It also reflects the main mechanism of postpartum haemorrhage: 
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failure of uterus to contract. The relaxed myometrium will fail to constrict the blood vessels, 
thereby allowing haemorrhage. Since up to one fifth of cardiac output, or 1000ml/min, enters 
the uteroplacental circulation at term, postpartum haemorrhage is capable of exsanguinating 
the mother within a short time. As uterine atony can result in retained placenta, the 
contraction failure often becomes self perpetuating. Uterine atony should be presenting in at 
least 70% of mothers with severe obstetric haemorrhage, but it was detected only in 30% in 
the current study. Uterine atony was identified in only 48% in a Scottish audit.25 The inclusion 
of early gestations may explain our higher percentage of retained placenta of 19% compared 
with reported figures of 10%.  
  
A larger percentage of unidentified causes might be due to the lack of either documentation or 
clinical recognition of uterine atony. This reflects the lack of being precise and specific when 
assessing severe obstetric haemorrhage. It seems that the inaccuracy in estimating blood loss 
and identification of causes of bleeding reflects the general management attitude towards 
severe postpartum haemorrhage. This inaccuracy might be one of the main underlying causes 
of inadequate management of severe PPH.  
The finding that the 60% of those who had caesarean delivery had no identified cause of 
associated severe haemorrhage indicates  a difficulty in identifying exact causes of 
haemorrhage at CS. CS is associated with higher risk for uterine atony, and surgical bleeding 
related to hysteretomy sites. Surgical bleeding is usually underreported due to lack of coded 
diagnosis even if recognised clinically. It is important to mention that placenta previa had the 
second highest risk for hysterectomy after uterine rupture in our population (Data not shown 
in papers). This may indicate the presence of placenta accreta, which is not specifically coded 
internationally. 
Although special ticked boxes contribute to better identification of causes than ICD codes, 
complete identification of causes is difficult to achieve. There would be still unidentified 
causes of haemorrhage even through following the case records, due to inadequate clinical 
recognition or documentation. A French study of obstetric haemorrhage based on case records 
found that uterine atony and retained placenta accounted for 80% of PPH after vaginal 
deliveries, while the cause remained unknown in 20% of PPH and 12% of severe PPH. 
Among haemorrhages at CSs, uterine atony was the most frequent cause, followed by 
hystertomy bleeding and placental abruption. In almost 50% of cases detected after CSs, no 
cause was identified.157 This is consistent with the results of our study. 
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Proportion of uterine rupture 
The proportion of uterine rupture was consistent with that in other countries,158  despite 
uncertainty due to including both incomplete and complete ruptures. This may indicate that 
the majority of ruptures estimated in our study are complete ruptures. This hypothesis is 
strengthened by the finding that 73% of prelabour ruptures were complete ruptures after 
reviewing the case records as shown in paper III.
Risk factors 
The final model in paper I determined the adjusted haemorrhage risk for delivery mode. We 
will be referring to the unadjusted OR of the other risk factors, as the delivery mode was an 
intermediate variable between these risk factors and severe obstetric haemorrhage. 
Demographic factors 
The risk of severe haemorrhage increased as maternal age was increasing. Mothers older than 
40 years old had the highest risk for severe haemorrhage and also for uterine ruptures in 
agreement with previous studies.6, 118-120,149 Studies suggested that older age is associated with 
increased risk for dysfunctional labour and deficient healing of uterine scar, contributing to 
increased risk for severe haemorrhage and uterine rupture.159  Mothers 40 years old had 4.5 
times increased risk for peripartum hysterectomy in our study. These results should be used in 
the debate against postponing childbearing to older age in modern societies.  
Grandmultiparity was not a risk factor for severe haemorrhage, probably due to few numbers 
of women with actually higher number of deliveries as 10 or more. In addition, this group is 
usually treated as high risk in labour, and thus the risk might be minimised by the vigilant 
obstetric care. In fact the primiparas were more at risk as they were predisposed to prolonged 
labour, operative vaginal deliveries and perineal trauma, consistent with recent studies.91, 122, 
148 Primiparas should have more attention during labour as they constitute potential candidates 
for CS on mother request in future pregnancies as a result of traumatic experience at 
childbirth.  
 
Immigrant women from non-Western background were shown in previous studies to have 
significantly higher mortality rate and adverse maternal outcomes.6, 16 This was attributed to 
their limited access to emergency and regular obstetric care compared with other women.  
Language barrier and communication difficulties contributed to suboptimal care provided for 
these mothers.  In our population, there was generally no significant difference in the risk for 
severe obstetric haemorrhage between mothers of Western and non-Western origin. This may 
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indicate equality in obstetric care. However, mothers of non-Western origin had significantly 
higher risk for uterine rupture in our population. This may be due to inadequate information 
on the obstetric history of these women, especially regarding the number and type of previous 
uterine scars.  
Women from South East Asia had the highest risk of severe obstetric haemorrhage, in 
contrast to women from the Middle East in our population. Both groups usually have severe 
haemorrhage as the leading cause of maternal deaths in their countries of origin.1–3 Why did 
the women from the Middle East have less risk for severe haemorrhage in Norway than in 
their original countries? This could be attributed to different characteristics of these women as 
compared with women in their original countries, or that they are getting better obstetric care 
in Norway.  We found in further analysis that immigrant women from the Middle East were 
youngest at childbirth, had the fewest elective CSs, and the highest vaginal delivery rates. In 
addition, they had lowest induction rate, lowest placenta previa or abruption and previous CS, 
and the lowest risk of perineal trauma, uterine atony and retained placenta.  
Mothers from South East Asia had the opposite characteristics and about 60% of them had a 
Norwegian partner. South East Asian mothers with Norwegian partner had significantly 
higher risk of severe obstetric haemorrhage than other South East Asian women. The former 
group had significantly higher percentage of infants with birth weight >3500 gm, fetopelvic 
disproportion, prolonged labour, shoulder dystocia, and operative deliveries. These results 
were not shown in tables in paper I.  
Previous CS 
Mother with previous CS had doubled risk of severe obstetric haemorrhage. They had higher 
risk than primiparas in our population. Having a previous CS is shown in several studies to 
increase severe haemorrhage and peripartum hysterectomy risk.47, 48 Even after excluding 
placenta previa and placental abruption, mothers with previous CS had significantly higher 
risk for severe haemorrhage than mothers without previous CS in our population.   
As the CS rate is increasing, uterine rupture is expected also to increase. The risk of uterine 
rupture depends on the number of uterine scars, and the type of previous uterine incision. The 
reported risk ranges from 4% to 9% for prior classical and T-shaped incision, whereas that 
reported for low vertical and low transverse ranges from 1% to 7% and 0.2% to 1.5%, 
respectively.160 Reviewing the case records demonstrated the importance of number and types 
of previous uterine scars in predicting uterine rupture even at latent uterine activity. Using 
ultrasound in such mothers might serve in reducing the number of ruptures occurring while 
waiting for planned repeated CS.161 
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Medical and pregnancy factors 
Our finding of increased risk for severe haemorrhage among mothers with cardiac disease was 
shown in a previous study suggesting association with uterine atony and operative vaginal 
deliveries.126 We need further studies on these women as there are increasing numbers who 
reach childbearing age. Clinical studies are warranted to find whether the use of 
anticoagulation or inadequate prophylaxis with oxytocin in third stage of labour are 
contributing to this increase in haemorrhage risk 
 von Willebrand’s disease, the commonest hereditary blood disorder, needs special attention 
as it had the highest odds for severe haemorrhage (4-fold increase) among pregnancy and 
medical complications. These mothers should have conjoined planning and management of 
delivery by haematologist, obstetrician, and anaesthetist prior to labour. The significant 
increase of severe haemorrhage by HELLP syndrome suggests coagulopathy as the 
underlying cause of haemorrhage. Coagulopathy in the form of disseminated intravascular 
coagulation is among the most common causes of fatality due to haemorrhage.96 The doubled 
risk carried by anaemia was shown in previous studies, with greatest impact in low resource 
settings.56, 120 The low reserve of blood volume in anaemic mothers leads to quicker 
decompensation than other women with similar blood loss.  Anaemia during pregnancy can 
be treated easily, and consequent prevention of chronic anaemia due to severe obstetric 
haemorrhage can be achieved. 
Multiple pregnancy and macrosomia were shown to increase severe haemorrhage in 
agreement with previous studies.6,70,86,87,90,148,149 This shows how certain risk factors are 
becoming more important due to changes in population demographics. The rate of multiple 
pregnancy is increasing due to increased assisted reproduction in increasing numbers of older 
women seeking pregnancy. Macrosomia is increasing partly as a result of increasing obesity 
and sedentary life style. 
Among mothers with previous CS, advanced gestational age increased the risk for uterine 
rupture in our population. This was in major part due to the higher induction rate at advanced 
gestational age. We believe that we need a larger sample to determine the effect of gestational 
age on uterine rupture. Previous studies with larger samples showed that gestational age was 
not a significant risk factor for uterine rupture.162 
Labour factors 
Prolonged labour was a significant risk factor that almost doubles the risk for severe 
haemorrhage, when controlled for relevant confounders prior to labour in agreement with 
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previous studies.70, 87, 163 However, it was not shown to increase the risk of uterine rupture 
after previous CS in our population.   
On the other hand, induction significantly increased the risk for both severe haemorrhage and 
uterine rupture as shown previously.6,70,  87, 128, 148 Prostaglandins had specifically significant 
risk for uterine rupture as shown in several studies.128, 164 
The finding that induction increased severe haemorrhage at all delivery modes reflects a 
pharmacological effect on uterine contractility and suggests uterine muscles exhaustion in the 
third stage as a consequence. Induction rate have increased in Norway up to 15% in 2008. The 
greatest increase was in the use of prostaglandins.85.  Compared with other countries, we in 
Norway are using a higher dose of prostaglandin and oxytocin in mothers with previous CS. 
As mechanical induction was shown to be relatively safer than other induction methods in our 
study, more efforts should be made toward using mechanical method instead of medical 
induction. 
The finding of uterine ruptures at emergency prelabour CS showed that uterine rupture can 
not be prevented even in the absence of established labour. However, the absence of serious 
maternal or perinatal outcomes after such ruptures showed that labour is the actual risk factor 
of catastrophic ruptures, and consequent prolonged intrapartum hypoxia. 
Delivery factors 
The finding that delivery by emergency CS carried the highest risk for severe obstetric 
haemorrhage (> 3-fold higher) was confirmed in several studies.6, 23, 28, 149, 165, 166 Uterine atony 
and surgical bleeding are expected to be the highest at emergency CS, especially CS in late 
labour. A previous Norwegian population-based cohort study showed that cervical dilatation, 
particularly one of 9–10 cm at the time of operation, was an independent risk factor for a 
blood loss of 1000 ml, transfusion and other complications166. That study found that an 
unexpectedly high number of caesareans were performed in the late stages of labour. 
Moreover, a UK study showed that 10% of emergency peripartum hysterectomies were 
performed after caesarean section at full dilatation due to failed progress in labour or failed 
delivery using instruments.28 This emphasizes the importance of performing emergency 
caesareans with the correct timing and for the correct indications. 
Our results confirmed that emergency CS after labour start had the highest risk for severe 
postpartum haemorrhage especially after induction. We analysed mothers with elective and 
emergency prelabour CS together in one group as prelabour CS in paper II. However, separate 
analysis performed by the author (not included in tables), showed that emergency prelabour 
CS had significantly lower risk for severe postpartum haemorrhage than emergency CS after 
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labour onset. This implies that labour especially in late stages is a detrimental factor in 
increasing severe haemorrhage. The risk of labour was at its maximum when it was 
performed after induction, ending in emergency CS in mothers with previous CS.  
 
We found that elective CS had higher risk for severe haemorrhage (2-fold higher) compared 
with spontaneous vaginal deliveries. Even operative vaginal deliveries carried lower risk than 
elective CS.  This finding and the finding that prelabour CS had significantly higher risk for 
haemorrhage compared with spontaneous labour, were not detected in previous studies.165 A 
recent study from Finland found similar results to ours.94 The increased risk for haemorrhage 
found at operative vaginal delivery was reported previously.70, 94, 120, 148  Our findings suggest 
an anticipation of increased severe haemorrhage at operative vaginal deliveries after induction 
among primiparas, mainly due to perineal trauma.  
Maternal outcomes 
Seven maternal deaths were identified after severe obstetric haemorrhage, representing a 
proportion of 2 /100 000 during our study interval from 1999-2004. This is much higher than 
the proportion of 0.6/100 000 reported previously in a review of maternal death in 1976-
1995.35 Our results might be less accurate as we relied solely on the registered data in MBRN, 
linked to the Registry of Causes of Death. In addition, the underlying causes of death were 
coded.  
The death/severe haemorrhage ratio in our population was 1: 500, based on the current study. 
This ratio is an indicator of our obstetric care. The satisfying case fatality estimate could be a 
result of an overestimation of haemorrhage cases leading to falsely low death/sever 
haemorrhage ratio. However, our ratio was lower than 1: 327 reported in a UK study using 
same inclusion criteria of severe haemorrhage as ours.6 The ratio of hysterectomy: severe 
obstetric haemorrhage was 1:100 in our study population.  
 
Hysterectomy is a major operation that saves lives, but is associated with major maternal 
morbidity and mortality. Many studies have found high complication rates 
for emergency peripartum hysterectomy, mainly due to the need for massive blood 
transfusion, coagulopathy, injury to the urinary tract, need for re-exploration because of 
persistent bleeding or complications caused by the hysterectomy itself, and febrile morbidity. 
28,29,47,48,101,103 After the correction we made, hysterectomy risk was 500 –fold increased after 
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severe haemorrhage. The most common cause of hysterectomy was uterine atony followed by 
placenta previa, retained placenta and uterine rupture.  
The majority of hysterectomies occurred at emergency CS after induction especially among 
mothers with previous CS (not shown in paper). This again indicates the severity of 
haemorrhage occurring as a result of emergency CS following induction.  
 In spite of the few cases identified with acute renal failure, the increased risk for this serious 
complication indicates the serious degree of hypoperfusion caused by obstetric 
haemorrhage.102 Our finding of increased risk for postpartum sepsis was found in previous 
studies.29, 48,100,101,104 Although only 7% of mothers with severe haemorrhage were admitted to 
ICU, severe obstetric haemorrhage represented the most common cause of maternal 
admissions to ICU (30%) in agreement with previous studies.117 
 
Perinatal outcome   
The same obstetric haemorrhage that threatens women’ survival can also cause death and 
disability in the newborns. In this study, mothers with severe haemorrhage had significantly 
larger proportion of serious perinatal outcome as perinatal death and post hypoxic 
encephalopathy compared with mothers without such complication. The highest odds for 
serious perinatal outcome were observed at very premature deliveries. The complication 
associated with the highest odds for serious perinatal outcome was uterine rupture, followed 
by placenta abruption in our study. The underlying risk factor of severe haemorrhage as 
prolonged labour was associated with increased risk for serious perinatal outcome due to 
increased risk for intrapartum hypoxia. 
Serious perinatal outcome after uterine rupture, though low in absolute number, resulted only 
if rupture occurred after trial of labour in this study. This indicates that avoiding prolonged 
duration of intrapartum hypoxia once rupture is suspected is the key for favourable perinatal 
outcome. The highest percentage of perinatal outcomes occurred when uterine rupture 
followed induction, reflecting the significant risks of induction in mothers with previous CS.  
Increasing trend of severe obstetric haemorrhage 
A disturbing trend of an unexplained and unexpected increased incidence of postpartum 
haemorrhage and severe postpartum haemorrhage was shown in recent studies in the 
developed world, including Canada, UK, Australia, and USA in last ten years.18 Maternal 
mortality from haemorrhage, however, remained static.  At the same time, there was an 
increased incidence of certain risk factors in the pregnant populations in these countries such 
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as increased CS rate, increased maternal age and immigrant mothers in addition to increased 
multiple pregnancy  and induction. However, the changes in these risk factors could not 
explain the rise in PPH rates.  It was postulated that other risk factors that are not easily 
identified or recorded in hospital data could be underlying causes of such increase in PPH. 
These factors include a more liberal approach to duration of labour, increases in obesity, or 
changes in management of third stage of labour, induction agents used or more complex 
interaction between different risk factors. Performance of large population studies in different 
countries was suggested in order to determine the incidence of severe obstetric haemorrhage, 
and whether this incidence is increasing, and to identify underlying risk factors contributing to 
such increases.18  
We tried to find out whether there is an increase in severe haemorrhage (>1500 ml) through 
the years of this study. We did not find, however any trend of increased incidence as we had a 
short interval of time.  
According to data from MBRN, there is a significant increase of obstetric haemorrhage 
>500ml from 1998 at 5.5% up to 16.8% in 2008.85 (Table 5). Table 5 shows the increase in 
certain procedures and events during labour especially prolonged labour, induction with 
prostaglandins and CS rate.85 The reported increase in obstetric haemorrhage might be partly 
due to a better case ascertainment as ticked boxes were introduced in 1999.35 
 
Table 5.  Percentage (%) of different events during labour in 1998 and 2008 in Norway85  
 1998 
(%) 
2008 
(%) 
 
Obstetric haemorrhage >500 ml 
 
 
7.7 
 
16.5 
Induction of labour 
 
11.2 15.2 
Induction with prostaglandins 
 
2.2 9.3 
Prolonged labour; FPD; Augmentation with 
oxytocin 
 
10.8 32.4 
Caesarean section (CS) 
 
13.5 17.1 
Epidural anaesthesia during labour 
(excluding CS) 
 
12.0 23.3 
Multiple pregnancy 
 
1.6 1.8 
   FPD:Feto-pelvic disproportion  
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IMPLICATIONS FOR LOW RESOURCE SETTINGS 
The significant risk of severe haemorrhage associated with CS is of particular importance in 
low resource settings. A sharp increase in CS has been observed in urban regions of countries 
in Asia, Africa and South-America,49  The use of operative vaginal delivery is low in these 
settings.  High fertility, increasing numbers of women with previous CS and increasing 
numbers of previous CSs in each mother might contribute a further increase in severe 
obstetric haemorrhage and case fatality due to severe haemorrhage. Anaemia is widespread 
among women of fertile age in low resource settings. In accordance with previous studies, we 
found a significant association of anaemia and severe haemorrhage. Such association might 
also play an important role in obstetric haemorrhage and its outcomes in low resource 
settings. Improving surgical skills to perform operative vaginal deliveries by childbirth 
attendants is a necessary task that should be achieved in these settings. All efforts should be 
directed toward implementing active management of the third stage of labour. This procedure, 
though simple, is of great importance for the prevention of atonic postpartum haemorrhage, 
especially when immediate access to emergency obstetric care is difficult. 
 
 
SUGGESTIONS FOR FUTURE STUDIES 
There are still several unresolved questions regarding severe obstetric haemorrhage. Important 
research questions for future research include:  
1)   Is there an increasing temporal trend in the incidence of severe obstetric haemorrhage and 
uterine rupture and their outcomes such as peripartum hysterectomy and maternal deaths?  
Population-based studies covering a longer interval of time and using MBRN would be a 
valuable data source for such research. Additional review of case records would provide us 
with information on the third stage management, maternal body mass index, and induction 
details, and eventually causes of maternal deaths. A validity study of MBRN regarding case 
ascertainment of severe haemorrhage or uterine rupture is needed to secure results with high 
reliability.  
2)   What are the causes of haemorrhage at CS? A review of case records could determine the 
exact causes, especially those related to surgical bleeding, intra-abdominal bleeding and 
placenta accreta.   
3)   What are the most important late maternal and perinatal consequences of severe obstetric 
haemorrhage? We suggest a study assessing the fertility and subsequent pregnancy outcome 
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in mothers with severe haemorrhage and uterine rupture. Additionally, studies assessing the 
long term effects of severe obstetric haemorrhage on the general health of both mother and 
infant are needed 
4)    How can we improve obstetric care in cases of severe haemorrhage and uterine rupture? 
A clinical audit study is recommended to assess the quality of obstetric care given for mothers 
identified with such complications. Case records of all mothers identified with severe 
obstetric haemorrhage/uterine rupture in MBRN data in the last 5 years could be reviewed so 
as to assess the management of individual cases. In addition, a prospective clinical audit 
should be established through risk management teams. The components of clinical 
management that would be assessed include mainly: communication, resuscitation, 
monitoring and investigation, and arresting the bleeding.25  
Our National Guidelines in Obstetrics and international guidelines from the Royal College 
and the American College of Obstetricians & Gynaecologists would be used as standards. 
CONCLUSION
This study showed that severe obstetric haemorrhage is a relatively frequent complication in 
Norway. The frequency and impact of severe haemorrhage can be effectively reduced by 
removing avoidable risk factors. Our findings call for reviewing labour management, 
particularly with regard to the use of CS and induction of labour. Our results indicate that 
mothers with previous CS constitute a high-risk risk group that should be managed with 
vigilance during pregnancy and labour. Careful selection of mothers with previous CS for trial 
of labour should be continued, and induction of labour with prostaglandins in mothers with 
previous CS should be questioned, with more effort toward using mechanical induction 
methods. Counselling of mothers with previous CS should include explanation of short and 
long term risks for both trial of labour and elective repeated CS. The finding that trial of 
labour carries greater risk and graver consequences of uterine rupture, compared with elective 
repeated CS, should be included in counselling. However, we should emphasize that the 
absolute number of such consequences is very low. Among mothers with previous CS, 
planned repeated CS is a better option than trial of labour if the chances of emergency CS are 
high. Other risk factors not amenable to change as age and ethnic origin can be minimised by 
extra vigilance. 
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ERRATA
The following errors were detected while writing this thesis: 
Paper I 
Table 2: 
Percentage with severe haemorrhage for cardiac disease should be 1.9%, not 1.1%. 
Table 3: 
Hysterectomy after severe haemorrhage should be 40 (114.2/10000), not 6 (17/10000) 
Hysterectomy without severe haemorrhage should be 7 (0.23/10000), not 1 
(0.0/10000). 
Odds ratio for hysterectomy: 
The correct odds ratio (OR) is: 501.76; 95% CI: 224.6–1120.8, not OR: 115.87; 95% 
CI: 25.92–517.92. 
Paper II 
Correct references: 
13. Pritchard JA, Baldwin RM, Dickey JC, Wiggins KM. Blood volume changes in 
pregnancy and the puerperium. II. Red blood cell loss and changes in apparent blood 
volume during and following vaginal delivery, cesarean section, and cesarean plus 
total hysterectomy. Am J Obstet Gynecol 1962;84:1271–82. 
Paper III 
-In page 3, line 23 under subheading ‘Perinatal outcome’, perinatal death was defined as 
intrapartum fetal deaths 28 weeks of gestation, and neonatal deaths seven or more days after 
birth, not related to congenital causes. The correct definition should be as follows: 
Intrapartum fetal deaths 28 weeks of gestation, or neonatal deaths seven or less days after 
birth, not related to congenital causes. 
The journal will be sent a written correction of this accidental error.  
In Table 5; page 9: OR values presented in the table were accidently exchanged between each 
of ’Prostaglandins, amniotomy and oxytocin’ and ’Oxytocin +/- amniotomy’; As can be seen, 
these results were statistically insignificant and have no impact on the overall results; The 
results should be as follows:  
Prostaglandins, amniotomy and oxytocin: 
OR (95% CI): 2.17 (0.5–8.9); OR** (95% CI): 2.01 (0.5–8.3). 
Oxytocin +/) amniotomy: 
OR (95% CI): 1.30 (0.5–3.6); OR** (95% CI): 1.22 (0.4–3.4). 
The journal will be sent a written correction of these accidental errors.   
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Hjemme, ikke planlagt
Under transport
Annet sted
Sikker
Usikker
Mors tidligere
svangerskap/fødte
Levende-
fødte
Dødfødte (24.
uke og over)
Spontanabort/Død-
fødte (12.–23. uke)
Spontanaborter
(under 12. uke)
Fødsel utenfor institusjon:
Annen prenatal
diagnostikk?
Nei
Ja, angi type:
Patologiske funn ved
prenatal diagnostikk? Ja, hvis bekreftet – spesifiser
Nei
Spesielle forhold
før svangerskapet:
Intet spesielt
Astma
Allergi
Tidligere sectio
Kronisk nyresykdom
Res. urinveisinfeksjon
Kronisk hypertensjon
Hjertesykom
Epilepsi
Diabetes type 1
Reumatoid artritt
Annet, spesifiser i «B»
Intet spesielt
Regelmessig kosttilskudd:
Nei
Spesifikasjon av forhold før eller under svangerskapet:
Før sv.sk. I sv.sk.
Multivitaminer
Folat/Folsyre
Legemidler i svangerskapet:
Nei
Ja – spesifiser i «B»
Spesielle 
forhold under
svangerskapet:
Blødning < 13 uke
Blødning 13–28 uke
Blødning > 28 uke
Glukosuri
Svangerskapsdiabetes
Hypertensjon alene
Preeklampsi lett
Preeklampsi alvorlig
HELLP syndrom
Preeklampsi før 34. uke
Eklampsi
Hb < 9.0 g/dl
Hb > 13.5 g/dl
Trombose, beh.
Forutsetter mors samtykke
– se rettledning på baksiden
Skriftlig orientering gitt til mor
Samtykker ikke for røykeoppl.
Røykte mor ved
sv.sk. begynnelse?
Nei
Av og til
Nei
Av og til
- ved sv.sk.
avslutning?
Daglig
Daglig
Ant. sig. dagl.:
Ant. sig. dagl.:
Mors
yrke
Samtykker ikke for yrkesoppl.
Ikke yrkesaktiv
Yrkesaktiv heltid
 Yrkesaktiv deltid
Mors yrke
Bransje:
Leie/presentasjon:
Normal
bakhode
Inngrep/tiltak
Ingen
Anestesi/analgesi:
Sete
Tverrleie
Avvikende hodefødsel
Annet, spesifiser i «C»
Fødselstart:
Spontan
Indusert
Sectio
Ev. induksjons-
metode:
Prostaglandin
Oxytocin
Amniotomi
Annet, spesifiser i «C»
Indikasjon for
inngrep og/eller 
induksjon
Komplikasjoner som beskrevet nedenfor
Fostermisdannelser
Overtid
Annet, spesifiser i «C»
Spesifikasjon av forhold ved fødselen/andre komplikasjoner
Ingen
Ingen
Placenta:
Normal
Fremhj. ved setefødsel:Utskj. tang, hodeleie Sectio:
Annen tang, hodeleie
Vakuumekstraktor
Episitomi
Vanlig fremhjelp
Uttrekning
Tang på etterk. hode
Utført som elektiv sectio
Utført som akutt sectio
Nei JaVar sectio planlagt før fødsel?
Annet:
Annet:
Komplikasjoner Vannavg. 12–24 timer
Vannavg. > 24 timer 
Mekaniske misforhold
Vanskelig skulderforløsning
Placenta previa
Abruptio placentae
Perinealruptur (grad 1-2)
Blødn.> 1500 ml, transf. Truende intrauterin asfyksi
Risvekkelse, stimulert
Langsom fremgang
Uterus atoniSphincterruptur (gr. 3-4)
Blødning 500–1500 ml
Eklampsi under fødsel
Navlesnorfremfall
Lystgass
Petidin
Epidural
Spinal
Pudendal
Infiltrasjon
Paracervical blokk
Narkose
Navlesnor Fostervann Komplikasjoner hos mor etter fødsel
Normal Normal Intet spesielt
Hinnerester
Ufullstendig
Infarkter
Koagler
Utskrapning
Manuell uthenting Velamentøst feste
Marginalt feste
Karanomalier
Omslyng rundt hals
Annet omslyng
Ekte knute Polyhydramnion
Oligohydramnion
Misfarget
Stinkende, infisert
Blodtilblandet
Feber > 38.5˚
Trombose
Eklampsi post partum
Mor overflyttet
Mor intensivbeh.
Sepsis
Annet, spesifiser
Placenta-
vekt
Navlesnor-
lengde:
Fødselsdato Klokken Pluralitet Barnets
vekt:
Total
lengde:
Eventuelt
sete–issemål:
1 min
5 min
Apgar score:
Hode-
omkrets:
Av
totaltNr.
Kjønn
Enkeltfødsel
Flerfødsel
For flerfødsel: Gutt
Pike
Ved tvil spesifiser i «D»
Barnet var:
Overfl. barneavd.
Neonatale diagn.:
(Fylles ut av
lege/pediater)
Tegn til
medfødte 
misdannelser:
Levendefødt
Nei
Nei
Ja
Ja
Intet spesielt
Dødfødt/sp.abort
For dødfødte: Død før fødsel
Død under fødselen
Ukjent dødstidspunkt
For dødfødte, oppgi også
Død før innkomst
Død etter innkomst
Levendefødt, død innen 24 timer Død senere (dato): Klokken
Livet
varte: Timer Min.
Dato:
Overfl. til Indikasjon for
overflytting:
Respirasjonsproblem
Prematur
Medfødte misd.
Perinatale infeksjoner
Annet, spesifiser
Hypoglyk. (< 2 mmol/l)
Medf. anemi (Hb < 13.5 g/dl)
Hofteleddsdyspl. beh. m/pute
Transit. tachypnoe
Resp. distress syndr.
Aspirasjonssyndrom
Intrakraniell blødning
Cerebral irritasjon
Cerebral depresjon
Abstinens
Neonatale kramper
Konjunktivitt beh.
Navle./hudinf. beh.
Perinat. inf. bakterielle
Perinat. inf. andre
Fract. claviculae
Annen fraktur
Facialisparese
Plexusskade
Systemisk antibiotika
Respiratorbeh.
CPAP beh.
Lysbehandlet
Utskifting
AB0 uforlik.
RH immunisering
Fysiologisk
Annen årsak
Behandlingskoder: Icterus behandlet:
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Spesifikasjon av skader, neonatale diagnoser og medfødte misdannelser – utfylles av lege
Jordmor v/fødsel:
Jordmor v/utskrivning:
Lege:
Mor:
Barn:
Melding om avsluttet svangerskap etter 12. uke – Fødsel, dødfødsel, spontanabort
Diabetes type 2
B
Røyking og yrke
C
For dødfødte: Usikkert kjønn
Oppgi dødsårsak i «D»
D
Protokollnr.: /
Se utfyllingsinstruks for blanketten på baksiden
Institusjonsnavn
Infeksjon, spes. i «B»
Annet, spesifiser i «B»
Årsak:
Mors
bokommune
Kryss av hvis skjema
er oppfølgingsskjema
Utskrivningsdato
Lege
barsel/barneavd:
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